Almirall MCP
An official MCP server providing structured access to Almirall's public website content, enabling AI agents to search indexed pages, retrieve specific content fragments, and discover product or company information while ensuring citations are preserved and restricted to the official domain.
Endpoint and access
No sign-in to connect and list tools. Individual tools may still need a vendor account, credentials, or permissions; check the documented prerequisites.
https://mcp.almirall.com/mcpWhat its tools do
14 tools, grouped by the hints the server advertises. Hints are self-declared, not verified behavior.
Checks and signals
Each line is separate evidence, not a trust score.
- Passed Endpoint answered the live check ·
- Passed Official MCP Registry namespace is tied to almirall.com ·
- Passed Endpoint is on the registry namespace domain ·
- Warning Advertises resources/templates/list but does not implement it
- Availability 1 of 1 checks passed in 30 days
What you can do with it
- Search general questions about Almirall
- Find product mentions and therapeutic areas
- Retrieve complete indexed pages
- Inspect structure of indexed content
Source and maintenance
Protocol and capabilities
- Server
- mcp-search-server 0.1.0
- MCP protocol negotiated in check
- 2025-11-25
- Tools
- 14 advertised
- Resources
- 500 captured; incomplete (item-cap)
- Resource templates
- Not advertised
- Prompts
- Not advertised
{
"tools": {
"listChanged": false
},
"resources": {
"listChanged": false
}
}Tools
14 advertised
search_tools — Search Tools
Find available Almirall MCP tools by name, purpose, or input. Returns complete tool definitions so a client can call a matching tool without loading the whole catalog.
{
"type": "object",
"required": [
"query"
],
"properties": {
"query": {
"type": "string",
"description": "Words describing the tool or task."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}search_content — Search Content
Primary tool for answering natural-language questions over indexed website and landing-page content. Use this whenever the user asks what a brand, product, or site says about ingredients, plant extracts, composition, contraindications, usage, benefits, claims, FAQs, or evidence. This includes questions that only mention a brand or product name, for example 'What ingredients or plant extracts does Physio Relax mention?'. Call this tool directly with the question even if domain or sourceId are unknown; those fields are optional narrowing filters, not required inputs. If you need to discover or disambiguate the indexed domain or sourceId for a second narrowed call, use list_sources. Searches content with keyword, semantic, and vector search, and can filter by domain, url, sourceId, or documentId. If no search results are found, the tool returns only a no-results text message in the query language when it can be detected. Use that message as the entire user-facing answer while preserving its meaning. The final answer must explicitly say that no sufficient information or indexed mention was found in Almirall's public content for the query, avoid confirming unsupported details, and suggest another question or Almirall's official channels. When this no-results message is returned, stop and do not add counts, bullet lists, related products, examples, search traces, or conclusions from auxiliary tool calls. Do not summarize, explain, or replace it with an unrelated response.
{
"type": "object",
"required": [
"query"
],
"properties": {
"top": {
"type": "integer",
"maximum": 30,
"minimum": 1,
"description": "Maximum number of search results to return. Defaults to the server setting."
},
"url": {
"type": "string",
"description": "Optional exact crawled page URL filter."
},
"query": {
"type": "string",
"description": "Natural-language question or keywords to search in crawled website content."
},
"domain": {
"type": "string",
"description": "Optional exact domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id, for example physio-relax-de."
},
"documentId": {
"type": "string",
"description": "Optional crawler document id to restrict results to one indexed page/document."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
},
"preferredLanguage": {
"type": "string",
"description": "Optional preferred language tag (for example es, en, or de). The value is echoed in the response as a client hint; indexed result text remains in its source language."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}get_chunk — Get Chunk
Retrieve one concrete indexed chunk by uid, or by documentId plus chunkIndex. Optionally returns adjacent chunks from the same document for context.
{
"type": "object",
"properties": {
"uid": {
"type": "string",
"description": "Exact Azure Search uid for the chunk."
},
"chunkIndex": {
"type": "integer",
"minimum": 0,
"description": "Chunk index inside the document."
},
"documentId": {
"type": "string",
"description": "Document id. Required when looking up by chunkIndex."
},
"contextAfter": {
"type": "integer",
"maximum": 5,
"minimum": 0,
"description": "Number of following chunks to include. Defaults to 0."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
},
"contextBefore": {
"type": "integer",
"maximum": 5,
"minimum": 0,
"description": "Number of previous chunks to include. Defaults to 0."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}get_page — Get Page
Reconstruct a page by documentId or url. Returns chunks ordered by chunkIndex plus a compact heading structure.
{
"type": "object",
"properties": {
"top": {
"type": "integer",
"maximum": 30,
"minimum": 1,
"description": "Maximum chunks to return. Defaults to 30."
},
"url": {
"type": "string",
"description": "Exact crawled page URL to reconstruct."
},
"domain": {
"type": "string",
"description": "Optional exact domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional source id filter, for example physio-relax-de."
},
"documentId": {
"type": "string",
"description": "Document id to reconstruct."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}get_source_map — Get Source Map
Build a navigable map of an indexed source or domain with pages, documents, headings, and chunk ranges.
{
"type": "object",
"properties": {
"top": {
"type": "integer",
"maximum": 30,
"minimum": 1,
"description": "Maximum chunks to inspect for the map. Defaults to 30."
},
"url": {
"type": "string",
"description": "Optional exact page URL filter."
},
"domain": {
"type": "string",
"description": "Optional exact domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id, for example physio-relax-de."
},
"documentId": {
"type": "string",
"description": "Optional document id filter."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}list_pages — List Pages
List indexed pages available within a sourceId or domain. Use this to discover which page URLs/documents exist before requesting a full page.
{
"type": "object",
"properties": {
"top": {
"type": "integer",
"maximum": 30,
"minimum": 1,
"description": "Maximum chunks to inspect for page discovery. Defaults to 30."
},
"query": {
"type": "string",
"description": "Optional search query to narrow page discovery. Use * or omit for broad discovery."
},
"domain": {
"type": "string",
"description": "Optional exact domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id, for example physio-relax-de."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}list_sources — List Sources
Discovery tool for indexed brands, sites, and domains. Use this when you need to discover or disambiguate which indexed domain/sourceId corresponds to a brand or product name, especially if an initial broad search needs narrowing. search_content does not require domain or sourceId, so prefer calling list_sources as an optional discovery step rather than as a mandatory prerequisite. It helps determine whether this MCP has a relevant indexed source and which domain or sourceId to pass into search_content or other tools.
{
"type": "object",
"properties": {
"top": {
"type": "integer",
"maximum": 1000,
"minimum": 1,
"description": "Maximum chunks to inspect for source discovery. Defaults to 30."
},
"skip": {
"type": "integer",
"minimum": 0,
"description": "Number of matching chunks to skip before collecting the next page of sources. Defaults to 0."
},
"query": {
"type": "string",
"description": "Optional query to list sources related to a topic. Use * or omit for broad source discovery."
},
"domain": {
"type": "string",
"description": "Optional domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id, for example physio-relax-de."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}find_pages_by_title — Find Pages by Title
Resolve the most relevant indexed pages by approximate title match before doing a narrower content search. Use this when the user mentions a brand, product family, or page-like concept but not a domain or URL, and you want to identify the right page first without requiring an exact title match.
{
"type": "object",
"required": [
"titleQuery"
],
"properties": {
"top": {
"type": "integer",
"maximum": 20,
"minimum": 1,
"description": "Maximum number of candidate pages to return. Defaults to 10."
},
"domain": {
"type": "string",
"description": "Optional domain filter to narrow title matching."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id to narrow title matching."
},
"titleQuery": {
"type": "string",
"description": "Brand, product, or page title hint to match approximately against indexed page titles."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}compare_content — Compare Content
Compare two or more named items, product formats, ranges, topics, or alternatives using indexed website content. Use this when the user asks for differences, similarities, pros/cons, or when to choose one option versus another, for example comparing Almax formats or Physiorelax ranges. Returns grouped evidence for each item so the client can build a grounded comparison.
{
"type": "object",
"required": [
"items"
],
"properties": {
"items": {
"type": "array",
"items": {
"type": "string"
},
"maxItems": 5,
"minItems": 2,
"description": "Names of the items or topics to compare."
},
"query": {
"type": "string",
"description": "Optional comparison context, such as ingredients, benefits, usage, format, contraindications, or when to choose each option."
},
"domain": {
"type": "string",
"description": "Optional domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id, for example physio-relax-de."
},
"topPerItem": {
"type": "integer",
"maximum": 10,
"minimum": 1,
"description": "Maximum number of search results to keep per item. Defaults to 3."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}find_product_mentions — Find Product Mentions
Specialized product extraction tool. Use when the user specifically asks what products a crawled brand/site offers, asks for catalog items, variants, product ranges, formulations, product benefits, ingredients by product, or where product claims appear. If the user is asking a general content question rather than enumerating products, use search_content instead. sourceId and domain are optional filters; if you need to discover the right indexed source before narrowing, use list_sources. Returns grouped product mentions with evidence snippets and real page URLs.
{
"type": "object",
"required": [
"query"
],
"properties": {
"top": {
"type": "integer",
"maximum": 30,
"minimum": 1,
"description": "Maximum number of search results to inspect for product mentions. Defaults to at least 8."
},
"query": {
"type": "string",
"description": "Natural-language query describing the product, brand, category, or benefit to detect."
},
"domain": {
"type": "string",
"description": "Optional domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id, for example physio-relax-de."
},
"productHint": {
"type": "string",
"description": "Optional known product or brand name to bias extraction and grouping."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}find_content_assets — Find Content Assets
Extract image/media asset URLs from indexed markdown text. Use only when the user asks for product images, media files, visual assets, screenshots, WordPress uploads, or image evidence. For textual questions about extracted page content, use search_content instead. Returns asset URLs plus the real page URL where each asset appeared.
{
"type": "object",
"properties": {
"top": {
"type": "integer",
"maximum": 30,
"minimum": 1,
"description": "Maximum number of chunks to inspect for assets. Defaults to at least 10."
},
"url": {
"type": "string",
"description": "Optional exact crawled page URL filter."
},
"query": {
"type": "string",
"description": "Optional topic, product, filename, or asset context to search before extracting assets. Defaults to image/product-oriented search."
},
"domain": {
"type": "string",
"description": "Optional exact domain filter, for example physio-relax.de."
},
"sourceId": {
"type": "string",
"description": "Optional crawler source id, for example physio-relax-de."
},
"userLocation": {
"type": "object",
"properties": {
"city": {
"type": "string",
"description": "City when available."
},
"region": {
"type": "string",
"description": "Region or state when available."
},
"country": {
"type": "string",
"description": "ISO country code when available, for example ES."
},
"timezone": {
"type": "string",
"description": "IANA timezone when available, for example Europe/Madrid."
}
},
"description": "Optional approximate user location. Include only if the client or user has explicitly made it available; do not infer or guess it."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}match_almax_prompt — Match Almax Prompt
Classify a Spanish prompt or phrase related to Almax into the closest editorial intent from the corpus. Use this when the client needs to detect which predefined Almax topic a user sentence matches before routing to another tool or template.
{
"type": "object",
"required": [
"text"
],
"properties": {
"text": {
"type": "string",
"description": "Phrase, prompt, or user text to classify."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}get_almax_dosage_calculator — Check Almax Label Dosage Limits
Calculate daily almagate grams for a standard dose of a supported Almax presentation and check the leaflet's age, 8 g/day and 14-day limits. daily_doses_intended means administrations per day, not tablets or sachets. This checks label limits only; it cannot establish individual clinical safety. treatment_days is needed to check duration.
{
"type": "object",
"required": [
"product_variant",
"patient_age",
"daily_doses_intended"
],
"properties": {
"patient_age": {
"type": "integer",
"minimum": 0
},
"treatment_days": {
"type": "integer",
"minimum": 1,
"description": "Planned number of days. Omit only if unknown; then the 14-day limit cannot be assessed."
},
"product_variant": {
"enum": [
"sobres",
"forte_comprimidos",
"comprimidos_500mg",
"frasco"
],
"type": "string",
"description": "Almax presentation. forte_comprimidos uses the 750 mg tablet leaflet; one standard dose is two tablets."
},
"daily_doses_intended": {
"type": "integer",
"minimum": 1,
"description": "Number of standard administrations per day; the standard dose size is determined by product_variant."
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}get_official_prospecto — Get Official Almax Prospectus
Return the indexed Markdown text of a prospectus PDF published on Almax.com for an explicit presentation, with the original PDF URL. This uses Almirall's indexed content and does not independently check the current AEMPS version.
{
"type": "object",
"required": [
"presentation_id"
],
"properties": {
"presentation_id": {
"enum": [
"forte-sobres",
"comprimidos-500mg",
"frasco",
"forte-comprimidos-menta",
"forte-comprimidos-cola",
"forte-comprimidos-fresa"
],
"type": "string"
}
}
}{
"readOnlyHint": true,
"openWorldHint": false,
"destructiveHint": false
}Prompts
Not advertised
Resources
500 captured; incomplete (item-cap)
¿Acidez en la boca? Este es el menú perfecto anti-acidez - Almax®
Texto indexado de https://www.almax.com/blog/acidez-en-la-boca-este-es-el-menu-perfecto-anti-acidez
almirall://content/almax-com/cf788e3626cc4f4a22b04f72e5ecfb3bd124fbf5c8fcfe0247ce88b238d392e8¿Ardor de estómago durante tu embarazo? - Almax®
Texto indexado de https://www.almax.com/blog/ardor-de-estomago-durante-tu-embarazo
almirall://content/almax-com/4ee2018371475b8d5ef1320a41fa736960f15e6ec292e0f1a0afcf034080e549¿Cómo saber si tengo acidez o ardor de estómago? - Almax
Texto indexado de https://www.almax.com/blog/como-saber-si-tengo-acidez-o-ardor-de-estomago
almirall://content/almax-com/dd0ed0f43ae82d12f18c23b1a1ce656cb1b10a687a53e8712c41cc51b214a3a1¿Cuáles son los alimentos que neutralizan la acidez? - Almax
Texto indexado de https://www.almax.com/blog/cuales-son-los-alimentos-que-neutralizan-la-acidez
almirall://content/almax-com/fdb26819e3120cafa9495c8321a25004a22b91a1cea23ca7745bb73d36a6c6a3¿Por qué siento ardor después de comer? - Almax
Texto indexado de https://www.almax.com/blog/por-que-siento-ardor-despues-de-comer
almirall://content/almax-com/9a2026b5e35dd5e8d8fc9dd9fe0b46cec3e645f9d48cc26d8b443d75c6bca40c¿Quitar el ardor con deporte? Alivia tus síntomas con yoga - Almax®
Texto indexado de https://www.almax.com/blog/quitar-el-ardor-con-deporte-alivia-tus-sintomas-con-yoga
almirall://content/almax-com/99a14582a6c32b424146da2ad76f0cb136002a7ac498857f8a54e26d7579c6a04 recetas rápidas y anti-acidez - - Almax®
Texto indexado de https://www.almax.com/blog/recetas/4-recetas-rapidas-y-anti-acidez-para-llevar-alla-donde-vayas
almirall://content/almax-com/b56c69559c9fc906c5bcef89484bb00d852bb6f538b553ed127cb7560ecf4005Acidez en el embarazo - Almax®
Texto indexado de https://www.almax.com/acidez-y-alivio/embarazo-y-acidez
almirall://content/almax-com/72346c221ce8daebf0bd1c91eb992edb46fccce98fbbd165c2abde5a9d8d3e95Adiós al ardor con tres meriendas antiácidas - Almax®
Texto indexado de https://www.almax.com/blog/adios-al-ardor-con-tres-meriendas-con-alimentos-antiacidos
almirall://content/almax-com/40e90316e1a41a3c253adad50769f7c811c79c66e83f0d5b62574b4a11cf3011Alivia la acidez con Almax® - Almax®
Texto indexado de https://www.almax.com/acidez-y-alivio/tratamiento-y-prevencion
almirall://content/almax-com/09628344239c03675ec7228d08ac58f87acddc412b464b8f9ce417052e514e14Almax 1g/7,5 ml suspensión oral en frasco - Almax®
Texto indexado de https://www.almax.com/productos/almax-frasco
almirall://content/almax-com/74cba52e267ec15c66e821e3934dfa5135e32d20ef125a8bd6445ef2255d6bb7Almax 500mg comprimidos masticables - Almax®
Texto indexado de https://www.almax.com/productos/almax-comprimidos-masticables
almirall://content/almax-com/2aa25c81bcf12259fce038a72ccd878d172696ea4954241ad54e6de62df2ba39Almax 500mg comprimidos masticables monodosis - Almax®
Texto indexado de https://www.almax.com/productos/almax-comprimidos-monodosis
almirall://content/almax-com/855f20de436acbee31c46999d8dc78cd45b3eafe8eb383a435afa7eec4da5435Almax Forte 1,5g suspensión oral en sobres - Almax®
Texto indexado de https://www.almax.com/productos/almax-forte-sobres
almirall://content/almax-com/7c5d85ad13a67aa072d38f413db76f6e77a8764aa828d727ecdad25605f86e89Almax Forte 750 mg comprimidos masticables sabor cola.html
Texto indexado de https://www.almax.com/wp-content/uploads/2025/02/Almax-Forte-750-mg-comprimidos-masticables-sabor-cola.html_.pdf
almirall://content/almax-com/0e781c4d2c406b67ab8e3d5bc37aafa9b83e562525535161ac122989dfb09831Almax Forte 750 mg comprimidos masticables sabor fresa.html
Texto indexado de https://www.almax.com/wp-content/uploads/2025/02/Almax-Forte-750-mg-comprimidos-masticables-sabor-fresa.html_.pdf
almirall://content/almax-com/39a3a57fd7d526f7b8d5fca294cfe9887c0c25ebabe666546dc6afca53b34eabAlmax Forte 750 mg comprimidos masticables sabor menta.html
Texto indexado de https://www.almax.com/wp-content/uploads/2025/02/Almax-Forte-750-mg-comprimidos-masticables-sabor-menta.html_.pdf
almirall://content/almax-com/386f13078a608eb70753843eadeaa801a462afe5502fbc521dd6cd089a8cff41Almax Forte 750mg comprimidos masticables - Almax®
Texto indexado de https://www.almax.com/productos/almax-comprimidos-forte
almirall://content/almax-com/78106af2e2933d43da5f188f5356b3bdc021bb140f76a9c28b42e71b67f29ba1Almax: actúa en 1 minuto contra la acidez - Almax®
Texto indexado de https://www.almax.com/
almirall://content/almax-com/6c1725a2b1391ddb576f75f712464e631f2324293f9df1cfd51656e1a78b94b2Ardor de estómago: causas, síntomas y tratamientos - Almax®
Texto indexado de https://www.almax.com/blog/ardor-de-estomago-causas-sintomas-y-tratamientos
almirall://content/almax-com/6a8522698bbb99e9b3d5c95c1c11c8bb9728623e80d16e81990f774c9a3b70ddBlog de Almax®: consejos de salud digestiva - Almax®
Texto indexado de https://www.almax.com/blog
almirall://content/almax-com/3ed9e6bbf8d1247647160eecf84b751fa4feb6d82e509198ac5dad284f033ed5Cómo evitar la acidez estomacal en tu rutina diaria - Almax
Texto indexado de https://www.almax.com/blog/como-evitar-acidez-estomacal
almirall://content/almax-com/ecde34d137bdab80db221790418ea46fd9503f9d867d40a5f44f48f5d576d007Condiciones de uso - Almax®
Texto indexado de https://www.almax.com/condiciones-de-uso
almirall://content/almax-com/61175f0126a439c792bd4ad617ed5e17a842c68a73d10c8848ccd9346a7d1dcaDescubre Almax - Almax®
Texto indexado de https://www.almax.com/descubre-almax
almirall://content/almax-com/ede72807bc8f0a23cf73363c354322a21c61b37dc7795e0b42f63312b6503c98Dieta FODMAP para la acidez - Almax
Texto indexado de https://www.almax.com/blog/dieta-fodmap-para-la-acidez
almirall://content/almax-com/66485937303b438b7963b99a47dd1b896a6ee6586f9883f6b201f75bc15f0c99Diferencia entre acidez y reflujo gástrico - Almax
Texto indexado de https://www.almax.com/blog/diferencia-entre-acidez-y-reflujo-gastrico
almirall://content/almax-com/5adbb3ee12e4f40faabcbd4bf12e092c4242848f1ce46cc0d713d346856b6143Evita la acidez nocturna con estos consejos - Almax®
Texto indexado de https://www.almax.com/blog/evita-la-acidez-nocturna-con-estos-consejos
almirall://content/almax-com/c85581f72afe65e6ff4d464f269918c177ce2b1cbda5b2417391bb1bc62ab8f5La avena, el mejor aliado contra la acidez gástrica - Almax®
Texto indexado de https://www.almax.com/blog/la-avena-el-mejor-aliado-contra-la-acidez-gastrica
almirall://content/almax-com/2fd823c0fae3d154504682bf8f58136c3d32ebd46bf971bdec32c107f8a6cd28Libérate de tu peor enemigo diario: la acidez gástrica - Almax®
Texto indexado de https://www.almax.com/blog/liberate-de-tu-peor-enemigo-diario-la-acidez-gastrica
almirall://content/almax-com/0beef8c366c2d1341d4142dd188cf731dc990c4110078eba60a05aabda466556Mitos sobre la acidez - Almax®
Texto indexado de https://www.almax.com/acidez-y-alivio/mitos
almirall://content/almax-com/34776f7b8790ed086ba125584b771c17f9bc2f953e689651a3f847fb329a4b75Motilidad gastrointestinal y acidez, ¿cómo se relacionan? - Almax
Texto indexado de https://www.almax.com/blog/motilidad-gastrointestinal-y-acidez
almirall://content/almax-com/7cd8bdd3841ec690c220b9bf00d58bc14c5d07728d6d0686bfe8ac9ae1860929Neutraliza la acidez con nuestros productos antiácidos - Almax®
Texto indexado de https://www.almax.com/productos
almirall://content/almax-com/ffce09c0e36a07bf2d8884e4b727cc9bd824c81d3d7b3a9314b7f5122c900dcaPolítica de Accesibilidad - Almax
Texto indexado de https://www.almax.com/politica-de-accesibilidad
almirall://content/almax-com/9a428d0cd85f8119d4cd3028ea375ff173ba38a9d7327fa340a7b85039f6ed73Política de cookies - Almax®
Texto indexado de https://www.almax.com/politica-de-cookies
almirall://content/almax-com/86a99703d118c634355cac341b28f64b0c1e88e19893db47a3dd9732f0a0469fPolítica de privacidad - Almax®
Texto indexado de https://www.almax.com/politica-de-privacidad
almirall://content/almax-com/0802a830bdf16507b77e6c07b7f7d1336b0fb352450f1dd9c45b5b471e64a13cPreguntas frecuentes - Almax®
Texto indexado de https://www.almax.com/preguntas-frecuentes
almirall://content/almax-com/8be9f0bc542a8ff10c4a2ffab317e81c574941efe0ee0200d6e915036264091bProspecto Almax 15g 75ml Frasco ES
Texto indexado de https://www.almax.com/wp-content/uploads/2024/09/Prospecto-Almax-15g-75ml-Frasco-ES.pdf
almirall://content/almax-com/1120d8e30ac72479daafdb8d0537fac306ff7319a0e27dfe6572a335810dcabcProspecto Almax 500mg Comprimidos Masticables ES
Texto indexado de https://www.almax.com/wp-content/uploads/2024/09/Prospecto-Almax-500mg-Comprimidos-Masticables-ES.pdf
almirall://content/almax-com/383b54e126c9a11852f8fd79c326c3fb3630cb8195ec408d8753f0775735084aProspecto Almax Forte 15g Sobres ES
Texto indexado de https://www.almax.com/wp-content/uploads/2024/09/Prospecto-Almax-Forte-15g-Sobres-ES.pdf
almirall://content/almax-com/6a85b1807e33a0fa789c2a6a95bc27eacaa011b27f964a7e091f3949dbd96ff3Síntomas de la acidez de estómago - Almax®
Texto indexado de https://www.almax.com/acidez-y-alivio/causas-y-sintomas
almirall://content/almax-com/6fbccf186a8582521b0ff1fe6dbc801f318d0067dea55d4c15fbeab3909f28d2¿Qué medicamentos tendrán nuestros hijos? Retos para equilibrar investigación y coste sanitario (only available in spanish) | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/que-medicamentos-tendran-nuestros-hijos-retos-para-equilibrar-investigacion-y
almirall://content/almirall-com/74943e97121f242bde4149f5faf9999295a74c467c0abc47f67948a431d87f0b“Hoy sí me puedo levantar”, a campaign in support of people living with Multiple Sclerosis (MS) | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/hoy-si-me-puedo-levantar-campaign-support-people-living-multiple-sclerosis-ms
almirall://content/almirall-com/f954a41e299a7a40b1616d7d0027c3f6492ca150af4c25a9d8842a9482b903bf“Moving aheAD”, by Almirall: A Message to Raise Awareness about Atopic Eczema | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/moving-ahead-almirall-message-raise-awareness-about-atopic-eczema
almirall://content/almirall-com/dc87829175567f8e493ab6340ce709b7b44c940b6ced3c24a26b1ddd5cb212b103062025 PR Almirall ESDaP Congress v26112975
Texto indexado de https://blob.almirall.com/files/documents/03062025_PR_Almirall_ESDaP%20Congress_v26112975.pdf
almirall://content/almirall-com/b2af2dd706f908c729fba4e255e60c893702d6d08214632153a52f9cc60c60dc060522 NP JuntaGeneraldeAccionistas def5146812
Texto indexado de https://blob.almirall.com/files/documents/060522_NP_JuntaGeneraldeAccionistas_def5146812.pdf
almirall://content/almirall-com/4370d2eca7695983f3429af90dbeeac950e90de333968fbf8036d24b814be87b06082025 PR Absci Almirall6168493
Texto indexado de https://blob.almirall.com/files/documents/06082025_PR_Absci-Almirall6168493.pdf
almirall://content/almirall-com/3b78f42c6342e2d572aee598371927082f86a12312e1993b20bd04996385c76f09112020 non exec vp nomination ENG4663263
Texto indexado de https://blob.almirall.com/files/documents/09112020%20non%20exec%20vp%20nomination%20ENG4663263.pdf
almirall://content/almirall-com/1698a19c2402608220bd408f81bbbabaf00300c1cd024c9624d5f552aaa4087a101120 PR Pablo Alvarez appointment ENG4665373
Texto indexado de https://blob.almirall.com/files/documents/101120_PR_Pablo%20Alvarez%20appointment_ENG4665373.pdf
almirall://content/almirall-com/7ee43968cf5456d6433d24ea3a4f7c55a086152fd335e3700118a1697c6bfa731047 EN Almirall moving forward in the development of aclidinium bromide165947
Texto indexado de https://blob.almirall.com/files/documents/1047_EN_Almirall_moving_forward_in_the_development_of_aclidinium_bromide165947.pdf
almirall://content/almirall-com/a9e16ff5e416870005cff1c763e067898fce082cad90fa1273b8b3495c18d0e41049 EN PR165966
Texto indexado de https://blob.almirall.com/files/documents/1049_EN_PR165966.pdf
almirall://content/almirall-com/7bb454ff948ca2f60aeff8684dc14730b321b9483211dceba25aa740eacf14331055 EN PR165985
Texto indexado de https://blob.almirall.com/files/documents/1055_EN_PR165985.pdf
almirall://content/almirall-com/ed12c85eb72c417a595d77e535ae41e05b21f5856f1903e2c8e0f3f41f8ab08c1057 EN Press release166004
Texto indexado de https://blob.almirall.com/files/documents/1057_EN_Press_release166004.pdf
almirall://content/almirall-com/c5506f61152718cf8191c4fb549c8605862a23c9b1b1443416295d3205543c161058 EN PR166023
Texto indexado de https://blob.almirall.com/files/documents/1058_EN_PR166023.pdf
almirall://content/almirall-com/571c2f2e64658eff0fd58d07138b1910f070d0124d9b4e3d3928a21e5e99d4f71061 EN PR166042
Texto indexado de https://blob.almirall.com/files/documents/1061_EN_PR166042.pdf
almirall://content/almirall-com/282cc138c6d3277e0c3a192530d324cbec29fafeb5571b103b20c3bbd3e4d9f71062 EN PR166061
Texto indexado de https://blob.almirall.com/files/documents/1062_EN_PR166061.pdf
almirall://content/almirall-com/da31b5366f00a65767d52f02facd9650d8785fb4310a4a119b7110c019bce2351063 EN PR166080
Texto indexado de https://blob.almirall.com/files/documents/1063_EN_PR166080.pdf
almirall://content/almirall-com/7b8b907d8ca77d15d986089d78c60b91792770a306c6711ade049b0b43c3b97f1068 EN NP LABA Almirall seeks partner166099
Texto indexado de https://blob.almirall.com/files/documents/1068_EN_NP_-_LABA_-_Almirall_seeks_partner166099.pdf
almirall://content/almirall-com/453e1d622e5e6fdf19d5ee67e69f8b9b9fb4bb056d8a735f03380eba6c36e0691092 EN PR166136
Texto indexado de https://blob.almirall.com/files/documents/1092_EN_PR166136.pdf
almirall://content/almirall-com/f5b5345b829a7d2f09d275fda32b066a497e85ecf25b99372c8d7407b04bf02e1102 EN PR166174
Texto indexado de https://blob.almirall.com/files/documents/1102_EN_PR166174.pdf
almirall://content/almirall-com/13e13f2dfff5fdd4bd4d31a65f531596bf56ba3b31f751bac75eb0912d5705aa110422 PR Lebrikizumab ADhere RAD 20225125852
Texto indexado de https://blob.almirall.com/files/documents/110422_PR_Lebrikizumab_ADhere_RAD_20225125852.pdf
almirall://content/almirall-com/705dcdf537add136f088e44d7301d4fb40884c1e28bf7221b9539c0e8fbeb5fa1105 EN PR166202
Texto indexado de https://blob.almirall.com/files/documents/1105_EN_PR166202.pdf
almirall://content/almirall-com/36c66a3d8ee4bc4a49dc1bd83d041242967a652db5cfa96fedf5fd563d3e790f1114 EN PR166230
Texto indexado de https://blob.almirall.com/files/documents/1114_EN_PR166230.pdf
almirall://content/almirall-com/ba1fa230f0ef0b8ff11016e7d59af8b0aca86ab73a3fa86cab56be0f3f6e4d411115 EN PR166249
Texto indexado de https://blob.almirall.com/files/documents/1115_EN_PR166249.pdf
almirall://content/almirall-com/bfd16911fdbca20786220ee1556ce747ea5d4a063bf64ad6ceb762579a4d6a371120 EN PR166268
Texto indexado de https://blob.almirall.com/files/documents/1120_EN_PR166268.pdf
almirall://content/almirall-com/30b6d5d612010df675b3558a6e950776518d6b8fa0fec36c4037bdfdc703d1451126 EN Press release regulatory submission final166287
Texto indexado de https://blob.almirall.com/files/documents/1126_EN_Press_release_regulatory_submission_final166287.pdf
almirall://content/almirall-com/7ce5cfd678d55638b3e613325fd11d00a08893540095c6c45a7653e2d76606271128 EN PR166306
Texto indexado de https://blob.almirall.com/files/documents/1128_EN_PR166306.pdf
almirall://content/almirall-com/0d92dbb4a01bd93441de86fe88d736584a85ca2906e879ba0fe7121496ce93391130 EN PR adolescents indication in USA english166325
Texto indexado de https://blob.almirall.com/files/documents/1130_EN_PR_adolescents_indication_in_USA_-_english166325.pdf
almirall://content/almirall-com/e3ffb69cfcb0131baffc060f96f68d5525cc35996c7bb518a50d4608bff322fd12042019 PR American Skin Association Award EN4152699
Texto indexado de https://blob.almirall.com/files/documents/12042019_PR_American_Skin_Association_Award_EN4152699.pdf
almirall://content/almirall-com/b84d7fdd91fa939c9508e7c250d1a5ba111da91a5bca3a81d265189fb12f858d1213 EN Press release166344
Texto indexado de https://blob.almirall.com/files/documents/1213_EN_Press_release166344.pdf
almirall://content/almirall-com/ae8a8cbfab04ef2f50435d9d3a779c48c6dc82e222995e18e2bae92f0c9688f21215 EN PR Health Safety166363
Texto indexado de https://blob.almirall.com/files/documents/1215_EN_PR_Health___Safety166363.pdf
almirall://content/almirall-com/3f1b4c6c1711569000320538c11a3994b6b8487be53041f3e7edc2e6a8e02aff1220 EN PR Results 2Q166382
Texto indexado de https://blob.almirall.com/files/documents/1220_EN_PR_Results_2Q166382.pdf
almirall://content/almirall-com/2baba644ad06decfcac13c9997100f8b989c9673c7b63326e2a27fe49dd9c1e91225 EN Almirall EU filing release english166401
Texto indexado de https://blob.almirall.com/files/documents/1225_EN_Almirall_EU_filing_release_english166401.pdf
almirall://content/almirall-com/908c591b36533ab65d042735005a7033020d7ec4836e8d75878d042fc423e1ae1227 EN PR Almirall Pharmacology Award 2009166420
Texto indexado de https://blob.almirall.com/files/documents/1227_EN_PR_Almirall_Pharmacology_Award_2009166420.pdf
almirall://content/almirall-com/539db917f01ec0bfa919f729d08f14f63ce34195962b5c0f03ca35a7c96ace871228 EN PR Blastoactiva166439
Texto indexado de https://blob.almirall.com/files/documents/1228_EN_PR_Blastoactiva166439.pdf
almirall://content/almirall-com/79540d110d59354bc8eae0acd9bd4cda5faada07457bd57eca3be315ca46700b1229 EN PR aclidinium BID166458
Texto indexado de https://blob.almirall.com/files/documents/1229_EN_PR_aclidinium_BID166458.pdf
almirall://content/almirall-com/31f85e0661ea37538074af393f948a0c6ac9224ced6ed32477727f67729134ea1241 EN PR Equity investment in Ironwood166477
Texto indexado de https://blob.almirall.com/files/documents/1241_EN_PR_Equity_investment_in_Ironwood166477.pdf
almirall://content/almirall-com/77cb478dafb0b62fb93608aa7bfa4e322b238d2ef4c321559ca593506313db261246 EN PR Almirall top 10 list166496
Texto indexado de https://blob.almirall.com/files/documents/1246_EN_PR_Almirall_top_10_list166496.pdf
almirall://content/almirall-com/d6da6b1777626215a045c6f24f50570dd1ee7e3610231debf190f5cd39b3275f1247 EN PR results Q3166515
Texto indexado de https://blob.almirall.com/files/documents/1247_EN_PR_results_Q3166515.pdf
almirall://content/almirall-com/7d7745519aa397b2b35fd8dd2c816d10c8013a73dedff6ec7f45fb9f30ee72791261 EN PR Positive opinion Silodosin166534
Texto indexado de https://blob.almirall.com/files/documents/1261_EN_PR_Positive_opinion_Silodosin166534.pdf
almirall://content/almirall-com/8594b00499ea69aaf31d97c3d42ff6be1a185cd17ed3106a0c2b37197d6487b21262 EN PR Launch Parapres Plus 32 and Forte166553
Texto indexado de https://blob.almirall.com/files/documents/1262_EN_PR_Launch_Parapres_Plus_32_and_Forte166553.pdf
almirall://content/almirall-com/9c2d6212616e478267ad4de00002a6fb595dd3b51b61642531801038082fb92b1265 EN PR LABA166572
Texto indexado de https://blob.almirall.com/files/documents/1265_EN_PR_LABA166572.pdf
almirall://content/almirall-com/dfc3e70053a3796f040cfb702320e5859a712eaf7e13510123ba40bbcf4824dd1306 EN ACCORD COPD I CL23 English final166591
Texto indexado de https://blob.almirall.com/files/documents/1306_EN_ACCORD_COPD_I_-_CL23_English_final166591.pdf
almirall://content/almirall-com/6d6631625d95ae7b8696aa3c616ccfc8341b0829c7398d48d8e587cbe3f070ee1315 EN PR Psychiatry symposium166610
Texto indexado de https://blob.almirall.com/files/documents/1315_EN_PR_Psychiatry_symposium166610.pdf
almirall://content/almirall-com/45077add88ecd398c6671318f1062b5c723f2640494a59460d2438c7f4fb316a1317 EN PR Eklira priority to BID English 166629
Texto indexado de https://blob.almirall.com/files/documents/1317_EN_PR_Eklira_priority_to_BID__English_166629.pdf
almirall://content/almirall-com/45eaed100c5023d5ce72a8c9f0621332aa4eeacb7af27cc2e94dc4f26164ccde1318 EN PR Silodosin166648
Texto indexado de https://blob.almirall.com/files/documents/1318_EN_PR_Silodosin166648.pdf
almirall://content/almirall-com/a2062bc7b8a1f7442072f74ac996b6f9ab0d0cd934b771dad63a87485de765521320 EN PR VAM meeting 166667
Texto indexado de https://blob.almirall.com/files/documents/1320_EN_PR_VAM_meeting_166667.pdf
almirall://content/almirall-com/3379014664dd8d0be652ec9a12f92d1dc7f9ebb4ae47ec737d8fa68a5a48943c1322 EN PR Neogenius166686
Texto indexado de https://blob.almirall.com/files/documents/1322_EN_PR_Neogenius166686.pdf
almirall://content/almirall-com/9ce05ffe29fa379b566c830661562b25b75006d4b9b7e927ab781ff79914550b1323 EN PR Results 09166705
Texto indexado de https://blob.almirall.com/files/documents/1323_EN_PR_Results_09166705.pdf
almirall://content/almirall-com/6ff274dfe5821a43504333a13c78cf43906e7f5ac369b6aed78cb068289889fb1356 EN PR Thiomucase extreme areas ing166724
Texto indexado de https://blob.almirall.com/files/documents/1356_EN_PR_Thiomucase_extreme_areas_ing166724.pdf
almirall://content/almirall-com/1987abd86a784b525e7a74a4210834a2f6bf196e2d1e38ead84e303bf0f501e71358 EN PR Cinitapride166743
Texto indexado de https://blob.almirall.com/files/documents/1358_EN_PR_Cinitapride166743.pdf
almirall://content/almirall-com/78485e2977eb680b9e71d45afa5a17cfa0cf9e90ad5f407a8ac8041ad5a7df461365 EN PR Ebastel166762
Texto indexado de https://blob.almirall.com/files/documents/1365_EN_PR_Ebastel166762.pdf
almirall://content/almirall-com/5f01037d4a2994d8095f883362310240347f460756359b0703a3ea8b690d0bfd1366 EN PR ATS 2010 final English166781
Texto indexado de https://blob.almirall.com/files/documents/1366_EN_PR_ATS_2010_final_English166781.pdf
almirall://content/almirall-com/fe9b528ba53f3f8aeae3b403bc3d76ca7fe2244572fc443fb8f01a8a0ef70f661370 EN PR Q12010 Results166800
Texto indexado de https://blob.almirall.com/files/documents/1370_EN_PR_Q12010_Results166800.pdf
almirall://content/almirall-com/6f8242ce8fd86163c18de380419e0dbe071dd6ff04801a2c23c8a9058078d4ae1371 EN PR166819
Texto indexado de https://blob.almirall.com/files/documents/1371_EN_PR166819.pdf
almirall://content/almirall-com/206f7e0a63f5d9b9226dc42d1a0bfe4cfa2474e3dc2aae2eeb1c99db042cee221375 EN Regulatory Update DCP Closure English final166838
Texto indexado de https://blob.almirall.com/files/documents/1375_EN_Regulatory_Update_-_DCP_Closure_English_final166838.pdf
almirall://content/almirall-com/2e88083f8006da0ba5f6456a0d9439f4e28bce473b7ec4184345f92024aaa92d1382 ES NdP centros de excelencia cardiologia junio10166852
Texto indexado de https://blob.almirall.com/files/documents/1382_ES_NdP_centros_de_excelencia_cardiologia_junio10166852.pdf
almirall://content/almirall-com/0f398544b56c5ae525fc92392d358fdba84480c8d2433d8e71fa0f615bb715e91385 EN PR Almirall Toctino English F166871
Texto indexado de https://blob.almirall.com/files/documents/1385_EN_PR_Almirall_-Toctino_English_F166871.pdf
almirall://content/almirall-com/74ce21790b809d1ca9a93252a6b642c2ff4d6597eef280a23f8d4a5d50f22e091391 EN PR166890
Texto indexado de https://blob.almirall.com/files/documents/1391_EN_PR166890.pdf
almirall://content/almirall-com/20cc988a3f5b2e76869831e46028e29c269c030593a3fbbdd3120a8d2d6f94491395 ES NP166904
Texto indexado de https://blob.almirall.com/files/documents/1395_ES_NP166904.pdf
almirall://content/almirall-com/0b8ab1c6c7d08bb6956df37eec6a36d971d97e6e4631e7ea58815f781b5f2de11399 EN PR166923
Texto indexado de https://blob.almirall.com/files/documents/1399_EN_PR166923.pdf
almirall://content/almirall-com/ea556e8e2352db18ff4a400f3d774902043d819090a03010165bf97fd5fe00d21400 EN PR166942
Texto indexado de https://blob.almirall.com/files/documents/1400_EN_PR166942.pdf
almirall://content/almirall-com/8b872de8585056fbe74a58ed67dd00e9b8c3db374fab12be82df4bffee715c51140203 Ndp Almirall Agreement (ENG)192952
Texto indexado de https://blob.almirall.com/files/documents/140203_Ndp%20Almirall%20Agreement%20(ENG)192952.pdf
almirall://content/almirall-com/193f371f331c8e53221a894682cd374169c885483a05a739546bd83baf9986571403 EN PR166980
Texto indexado de https://blob.almirall.com/files/documents/1403_EN_PR166980.pdf
almirall://content/almirall-com/b246a630d4a22a6895dbc7b6cd490533e5c52b17aa12661f530fbe180e7745b81406 EN PR166999
Texto indexado de https://blob.almirall.com/files/documents/1406_EN_PR166999.pdf
almirall://content/almirall-com/4bd94a3b7eddf9897564a164ba088cc29d0cad0a97a531f6de8647800e20f5541409 EN Study 1 Ph3 IBS C final167018
Texto indexado de https://blob.almirall.com/files/documents/1409_EN_Study_1_Ph3_IBS-C_final167018.pdf
almirall://content/almirall-com/adc07bda1ab19a69651adc894c1e66d1f49e2a891bc1496734f250b2680043701410 EN PR167037
Texto indexado de https://blob.almirall.com/files/documents/1410_EN_PR167037.pdf
almirall://content/almirall-com/90cf06b97c6557ba48287b4131bbd24921af5550735ea83c521f78d8858727651413 EN PR Pharmacology Award167056
Texto indexado de https://blob.almirall.com/files/documents/1413_EN_PR_-_Pharmacology_Award167056.pdf
almirall://content/almirall-com/4e891e8493310ebc2242e9667450310ca53256e4d20f2dc6893cdd3bba16e5701417 EN PR Conbriza s approval by the AEM167075
Texto indexado de https://blob.almirall.com/files/documents/1417_EN_PR_Conbriza_s_approval_by_the_AEM167075.pdf
almirall://content/almirall-com/014becfe143ea24f61b9a4046479cbbd259486a9b1f21b20f7f2a448c779a5dc1418 EN PR Launch of silodosin167094
Texto indexado de https://blob.almirall.com/files/documents/1418_EN_PR_Launch_of_silodosin167094.pdf
almirall://content/almirall-com/3abd28430935a4844f2dc23b6089f1c5457ef041720ca7bbdb26f2f6f26c4ee61419 EN PR OHSAS renovation167113
Texto indexado de https://blob.almirall.com/files/documents/1419_EN_PR_OHSAS_renovation167113.pdf
almirall://content/almirall-com/f8f95184668973ff75c7ad17528af811cba7a2a88a60b91b9c054ed43bd5efec1421 EN ECTRIMS press release final167132
Texto indexado de https://blob.almirall.com/files/documents/1421_EN_ECTRIMS_press_release_final167132.pdf
almirall://content/almirall-com/e8452a94f5e81defd1e8a8291a8cf6265e714fad77ad6d9af5c6a2b9af7f8d211422 ES NP Dia Mundial de la Diabetes167146
Texto indexado de https://blob.almirall.com/files/documents/1422_ES_NP_Dia_Mundial_de_la_Diabetes167146.pdf
almirall://content/almirall-com/bc027e270eb053fd3a88ba6cc75a302ee2a66cbcff60263c6be94c1055237de41424 EN ACCORD COPD II results english167165
Texto indexado de https://blob.almirall.com/files/documents/1424_EN_ACCORD_COPD_II_results_english167165.pdf
almirall://content/almirall-com/369cffe10638f09e6f826fccb1492549372badf247f643bd999ffc6a016f63de1428 EN MCP 103 302 results final press167184
Texto indexado de https://blob.almirall.com/files/documents/1428_EN_MCP-103-302_results_final_press167184.pdf
almirall://content/almirall-com/8ef192b2536f15544d1efc5fb8dd21396e228364fd42dfa73e4f8dedbbd406b41430 EN PR Q3 results 15nov10167203
Texto indexado de https://blob.almirall.com/files/documents/1430_EN_PR_Q3_results_15nov10167203.pdf
almirall://content/almirall-com/c62bd828996c74d98b0de7c85ec223c57bc984ef4ca58ab800b51cd81a5830161434 EN Cancer Pain Phase III English167222
Texto indexado de https://blob.almirall.com/files/documents/1434_EN_Cancer_Pain_Phase_III_-_English167222.pdf
almirall://content/almirall-com/b99473ed5387ddd2db36a8dfc2ac01ea407e874f8c7c6e280d31ab8b4cce57391442 EN ATTAIN press release final press167241
Texto indexado de https://blob.almirall.com/files/documents/1442_EN_ATTAIN_press_release_final_press167241.pdf
almirall://content/almirall-com/da6c02a800632c38f91453e28081de25bd40f6da9f9cd3d618668727af283c731448 EN Appointment Almirall s Executive Director R D Dr Lindma 167260
Texto indexado de https://blob.almirall.com/files/documents/1448_EN_Appointment_Almirall_s_Executive_Director_R_D_-__Dr_Lindma_167260.pdf
almirall://content/almirall-com/85287ecbdc0f8ca025713c15346238bceb4f1d6f20c84dbba627b50dc321582c1451 ES NP Congreso Psiquiatria enero11 167274
Texto indexado de https://blob.almirall.com/files/documents/1451_ES_NP_Congreso_Psiquiatria__enero11_167274.pdf
almirall://content/almirall-com/fb2a51ae969ad25d1e673515ce871c6cbee959abaa2bceca66b8fe9fabfaee9e1456 EN Almirall Mexico recibe el distintivo de Empresa con Practi 167293
Texto indexado de https://blob.almirall.com/files/documents/1456_EN_Almirall_Mexico_recibe_el_distintivo_de_Empresa_con_Practi_167293.pdf
almirall://content/almirall-com/131c47c77a22ab6c53a6a877e9d6eaeff03e836877cbbe9ec2fcd3fc716676571458 EN Press release reimbursement Spain for Sativex final167312
Texto indexado de https://blob.almirall.com/files/documents/1458_EN_Press_release_reimbursement_Spain_for_Sativex_final167312.pdf
almirall://content/almirall-com/4db5d0ab2a28e113250be92892ac12ebe9f98c012260719cdca2d0044a9c0dab1459 ES NP Reunion VAM Almirall. feb11167326
Texto indexado de https://blob.almirall.com/files/documents/1459_ES_NP_Reunion_VAM_Almirall._feb11167326.pdf
almirall://content/almirall-com/65a313c67808321be43dadf3799b125115c150262c376b729be55845bc67fe931462 EN Appointment E Crespo General Director Industrial Area February11 167345
Texto indexado de https://blob.almirall.com/files/documents/1462_EN_Appointment_E_Crespo_General_Director_Industrial_Area__February11_167345.pdf
almirall://content/almirall-com/19413f0496120244b76bc660fa260caa0d8c6beb77e4fb0a22b640f61291b8ce1463 EN Almirall and Kyorin announce a licensing agreement in Japa 167364
Texto indexado de https://blob.almirall.com/files/documents/1463_EN_Almirall_and_Kyorin_announce_a_licensing_agreement_in_Japa_167364.pdf
almirall://content/almirall-com/cb78d1e75baf59837f023ab644e0d069ac49063107a4f714e85a50782979be981464 EN Almirall 2010 financial results in line with guidance167383
Texto indexado de https://blob.almirall.com/files/documents/1464_EN_Almirall_2010_financial_results_in_line_with_guidance167383.pdf
almirall://content/almirall-com/d5e1b427ec081591632bd10f98aec6ef19c47266d1c5ce9e2c99d43e70b88b1d1467 EN Press release launch of Sativex in Spain final167402
Texto indexado de https://blob.almirall.com/files/documents/1467_EN_Press_release_launch_of_Sativex_in_Spain_final167402.pdf
almirall://content/almirall-com/6039805dd4af7923d943fc86f791e8049c333d80db13f544a334c88b444f04211469 EN Appointment ESanchiz as new CEO167421
Texto indexado de https://blob.almirall.com/files/documents/1469_EN_Appointment_ESanchiz_as_new_CEO167421.pdf
almirall://content/almirall-com/a97d3537b30cef012fc93d97fae663e4324d8f5a3db5d993ac142791d07e133a1473 ES NP Lanzamiento Balneum Intensive Espa a167435
Texto indexado de https://blob.almirall.com/files/documents/1473_ES_NP_Lanzamiento_Balneum_Intensive_Espa_a167435.pdf
almirall://content/almirall-com/f17c4f194350b3f0fd691d4ef0de89cf707304c67f1e8d44addd970e222781451475 EN Sativex MRP day 90 press release167454
Texto indexado de https://blob.almirall.com/files/documents/1475_EN_Sativex_MRP_day_90_press_release167454.pdf
almirall://content/almirall-com/f42f8d38716444a881ac41c1edc8c98e1c582e2308d0eb3a2012554053c6d9981477 EN PR Excellent Profarma167473
Texto indexado de https://blob.almirall.com/files/documents/1477_EN_PR_Excellent_Profarma167473.pdf
almirall://content/almirall-com/6c6febed6399189783ec4872d9ff938fbaa81df1dffa1cdb937ab851cfe69ac41478 EN Ignasi Marti Rague Director Institutional Relations167492
Texto indexado de https://blob.almirall.com/files/documents/1478_EN_Ignasi_Marti_Rague__Director_Institutional_Relations167492.pdf
almirall://content/almirall-com/77a688ee2923cdd255e4110dd9168ed986ddffcaa6d4c3c4619044a3d5d175841482 ES NP Almirall apuesta por la formacion en liderazgo a g 167506
Texto indexado de https://blob.almirall.com/files/documents/1482_ES_NP_Almirall_apuesta_por_la_formacion_en_liderazgo_a_g_167506.pdf
almirall://content/almirall-com/6a5a0c4dfacc45a897f0a0c4f25c822e390de5217a20e501f9ac933767f512931483 EN LAS190792 MABA press release final167525
Texto indexado de https://blob.almirall.com/files/documents/1483_EN_LAS190792__MABA__press_release_final167525.pdf
almirall://content/almirall-com/5341b6af2e2b51f55999452c4bfce1c2b43e92095a24fefc6b0d769650d5c7851485 ES VII Simposium Respiratorio167539
Texto indexado de https://blob.almirall.com/files/documents/1485_ES_VII_Simposium_Respiratorio167539.pdf
almirall://content/almirall-com/7898afe04ec54b890fc2dbbbaef3f476956fb2fe83a2e8dee5fb26c490fc4e831495 EN PR AlmirallNycomed roflumilast agreement167558
Texto indexado de https://blob.almirall.com/files/documents/1495_EN_PR_AlmirallNycomed_roflumilast_agreement167558.pdf
almirall://content/almirall-com/ed8ec4f8a84c01f2a3ef562257832e6daf29ceb8dcb2d3aff2e7e279e8cc57771496 EN NP Junta General English 2011 final167577
Texto indexado de https://blob.almirall.com/files/documents/1496_EN_NP_Junta_General__English__2011_final167577.pdf
almirall://content/almirall-com/8875509e95d65e2a9dc8f3d48b691e9fdf8dcab82d88d8fe570933def35864071497 EN PR Regulators confirm Actikerall is approvable English 167596
Texto indexado de https://blob.almirall.com/files/documents/1497_EN_PR_Regulators_confirm_Actikerall_is_approvable__English_167596.pdf
almirall://content/almirall-com/373c3094e2fe977070ca30f4ec00fee9d5dc68ba97deeaf29d6936e4e496df0a1498 EN ATS PR167615
Texto indexado de https://blob.almirall.com/files/documents/1498_EN_ATS_PR167615.pdf
almirall://content/almirall-com/32ac4dc401ab4f8804da367ed564314a7b2d11bf0ff097f2752b0151e762f4421499 EN PR Q1 2011 Results English v FINAL167634
Texto indexado de https://blob.almirall.com/files/documents/1499_EN_PR_Q1_2011_Results__English__v_FINAL167634.pdf
almirall://content/almirall-com/fccf4e36a028c8d9dc27bedf1956106bef9e729a75b9789f8f260955c856ae2814th September, World Atopic Eczema Day | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/14th-september-world-atopic-eczema-day
almirall://content/almirall-com/dda964612f974a34b580367afa2ddd0597fc6440f1430379fb813b0a5c9aa39e1503 EN PR Regulatory approval in Germany English final167653
Texto indexado de https://blob.almirall.com/files/documents/1503_EN_PR_Regulatory_approval_in_Germany_English_-_final167653.pdf
almirall://content/almirall-com/5b5500f6cce82c4e0f84ba8627ce7b9c5b887e67cde5600aecb94d54cbfd63a9150414 2014 Annual Report Baixa
Texto indexado de https://blob.almirall.com/files/2026-01/150414_2014_Annual_Report_Baixa.pdf
almirall://content/almirall-com/475edc0a820955fba5f74221acb927e13bebfa1be152f11ab19d3269a71fd1ed1506 EN EMSP press release final167672
Texto indexado de https://blob.almirall.com/files/documents/1506_EN_EMSP_press_release_final167672.pdf
almirall://content/almirall-com/fb80fc7137e1a7637b1ff7e2471466d2e1d616b5c35808229749a8e76603347a1507 EN Appointment Daniel Martinez Carretero CFO167691
Texto indexado de https://blob.almirall.com/files/documents/1507_EN_Appointment_Daniel_Martinez_Carretero_-_CFO167691.pdf
almirall://content/almirall-com/c4ed791ade499e4055d0ac0992ee14907e28c038dd3001954ec5dc2753cad5cd1510 EN Actikerall UK launch release final167710
Texto indexado de https://blob.almirall.com/files/documents/1510_EN_Actikerall_UK_launch_release_final167710.pdf
almirall://content/almirall-com/e4900c1a9624e84aed0aeba8dadc0c768b544fb02368f91c9678da2e0094ef2b1511 EN Sativex approved in Denmark final167729
Texto indexado de https://blob.almirall.com/files/documents/1511_EN_Sativex__approved_in_Denmark_final167729.pdf
almirall://content/almirall-com/0211c82f86e21f752869d9196c284ddf49787b0b899cb3b027748ff9f918f99c1513 ES NP Libro Patologia Digestiva167743
Texto indexado de https://blob.almirall.com/files/documents/1513_ES_NP_Libro_Patologia_Digestiva167743.pdf
almirall://content/almirall-com/44045b7f1580416313146fb38ccf080bc8b534be9d4d6e4f09dad308bda86fbd1514 ES NP Almirall empresa comprometida con la formacion de gestores sanitarios167757
Texto indexado de https://blob.almirall.com/files/documents/1514_ES_NP_Almirall__empresa_comprometida_con_la_formacion_de_gestores_sanitarios167757.pdf
almirall://content/almirall-com/3edd0cb5d28561caebb869f99af44e1623840555962b57775842049ed80ce31a1515 ES Nuevos dato avalan la seguridad y eficacia del bazedoxifen 167771
Texto indexado de https://blob.almirall.com/files/documents/1515_ES_Nuevos_dato_avalan_la_seguridad_y_eficacia_del_bazedoxifen_167771.pdf
almirall://content/almirall-com/c3d31dcf96c4c45f6cb492b5b633631b47009ede2d19972d130af0a6a8d52b251518 EN Aclidinium NDA Announcement Release FINAL167790
Texto indexado de https://blob.almirall.com/files/documents/1518_EN_Aclidinium_NDA_Announcement_Release_-_FINAL167790.pdf
almirall://content/almirall-com/b6e63539dfe0b42570802906807330762b3387708a51d65dfd643a1748a44cdb1520 EN PR Appointment Farid Taha GM Germany Austria and Switzerland167809
Texto indexado de https://blob.almirall.com/files/documents/1520_EN_PR_Appointment_Farid_Taha_-_GM_Germany__Austria_and_Switzerland167809.pdf
almirall://content/almirall-com/49ff89ab8e1b83b0d9a3b1f7464b5001db1481568fdf67a7068642c51002351d1521 EN Launch of Sativex and Actikerall in Germany167828
Texto indexado de https://blob.almirall.com/files/documents/1521_EN_Launch_of_Sativex_and_Actikerall_in_Germany167828.pdf
almirall://content/almirall-com/7ba1e4f410589bb980bbe58c2980a7f024a04b4bf8a10b428f7121accd6f0fb31539 EN Aclidinium EU Filing Release final English167847
Texto indexado de https://blob.almirall.com/files/documents/1539_EN_Aclidinium_EU_Filing_Release_final_English167847.pdf
almirall://content/almirall-com/cef23dc05e27dc05d048d7a84fa0586e681b3ea3bc5348529bff8e38bd05bdbc1540 EN PR H1 2011 Results English167866
Texto indexado de https://blob.almirall.com/files/documents/1540_EN_PR_H1_2011_Results__English167866.pdf
almirall://content/almirall-com/c3418ec3e9764d332f99d2611798761252a1e01c0890df259551a68a15937c721556 EN PR Appointment Alfredo Baron167885
Texto indexado de https://blob.almirall.com/files/documents/1556_EN_PR_Appointment_Alfredo_Baron167885.pdf
almirall://content/almirall-com/e990f7c47f9c1d878d7a89abd30d03e39db1093b191f195a31bdd5548b11a0f01558 EN Almirall enters into Integrated Discovery agreement with P 167904
Texto indexado de https://blob.almirall.com/files/documents/1558_EN_Almirall_enters_into_Integrated_Discovery_agreement_with_P_167904.pdf
almirall://content/almirall-com/9c441777b59cd2ce5eae943cf509050dd0d038623a668ef96d89b1cc91c0decd1559 EN Aclidinium ERS 2011 Press Release English167923
Texto indexado de https://blob.almirall.com/files/documents/1559_EN_Aclidinium_ERS_2011_Press_Release_English167923.pdf
almirall://content/almirall-com/91fcbe7f506ef3724afa78cfd2f8024744ff22b2b879bff585112f40ee1b160f1560 ES NP Presentacion Guia osteoporosis OMC septiembre11167937
Texto indexado de https://blob.almirall.com/files/documents/1560_ES_NP_Presentacion_Guia_osteoporosis_OMC_septiembre11167937.pdf
almirall://content/almirall-com/3ab16c45736e1a466b87df201c1f8e456ccc6cb7bc8fe8653f2ad75b23e4fd2c1561 EN Linaclotide EU Filing Release English final167956
Texto indexado de https://blob.almirall.com/files/documents/1561_EN_Linaclotide_EU_Filing_Release_English_final167956.pdf
almirall://content/almirall-com/d708e34be02a823108723ea7d65b2bbeacedeceedc21fed20148a74053b3c3a31562 EN PR Almirall and Nycomed announce a licensing agreement for 167975
Texto indexado de https://blob.almirall.com/files/documents/1562_EN_PR_Almirall_and_Nycomed_announce_a_licensing_agreement_for_167975.pdf
almirall://content/almirall-com/4d2b7e8f9185415563c88f1f20ea249b0de40631dc87c366fe802650113cbb131564 EN PR Almirall launches roflumilast in Spain Oct 11167994
Texto indexado de https://blob.almirall.com/files/documents/1564_EN_PR_Almirall_launches_roflumilast_in_Spain_Oct_11167994.pdf
almirall://content/almirall-com/f55af5f9d9be3576c6edf8eba13014c91d7684946e3ccd44dc46497f151ace161567 EN Almirall and the Spanish Pharmacological Society recognise research into diabetes168008
Texto indexado de https://blob.almirall.com/files/documents/1567_EN_Almirall_and_the_Spanish_Pharmacological_Society_recognise_research_into_diabetes168008.pdf
almirall://content/almirall-com/7933df5bcc6d852383ecd32435cfb0c102659595098fabec7d6a40a67c4e1b661572 EN UEGW data press release168046
Texto indexado de https://blob.almirall.com/files/documents/1572_EN_UEGW_data_press_release168046.pdf
almirall://content/almirall-com/06c12c1b348ba73a57d2f9cd53183fba6d5d5d647159a30fbba0ddc6363bd9e21573 EN ECTRIMS press release168065
Texto indexado de https://blob.almirall.com/files/documents/1573_EN_ECTRIMS_press_release168065.pdf
almirall://content/almirall-com/8d6f2570f36cf67643bbd02f32ef4603e3c822491ac3d7508770b3684b98473c1589 EN NP general DM EPOC MADRID168084
Texto indexado de https://blob.almirall.com/files/documents/1589_EN_NP_general__DM_EPOC_MADRID168084.pdf
almirall://content/almirall-com/9abfe3392dc9165ef30a3a5f260afa3e127fd70a02cd54582d993bebc89675101590 EN q3 results almirall prepares fo future growth final168103
Texto indexado de https://blob.almirall.com/files/documents/1590_EN_q3_results_almirall_prepares_fo_future_growth_final168103.pdf
almirall://content/almirall-com/36687480fc5810e8fc7c88d31e08d20a5f3018cd8464610985f395652ae3446b1593 EN Ndp estudio Diabcontrol nov11168122
Texto indexado de https://blob.almirall.com/files/documents/1593_EN_Ndp__estudio_Diabcontrol__nov11168122.pdf
almirall://content/almirall-com/1a29d81b0c4a68bb8b078ef3aa3b6716f901df2fecb662e1eb2fd75d899f5bf51594 EN Ndp. Almirall Dia Mundial de la Diabetes nov11168141
Texto indexado de https://blob.almirall.com/files/documents/1594_EN_Ndp._Almirall_Dia_Mundial_de_la_Diabetes_nov11168141.pdf
almirall://content/almirall-com/1531bae1ae3ed81f5791583e33e47d724e94d52154e2151ee33b7d991f4904e71595 EN PR Collaboration Almirall BioFocus Nov168160
Texto indexado de https://blob.almirall.com/files/documents/1595_EN_PR_Collaboration_Almirall_BioFocus_Nov168160.pdf
almirall://content/almirall-com/c5d1481d361a6350f93d703514efe93fe51b1371b7584693afc28744db3ea5351596 EN AB+For Phase III press release final168179
Texto indexado de https://blob.almirall.com/files/documents/1596_EN_AB%2BFor_Phase_III_press_release_final168179.pdf
almirall://content/almirall-com/159c523c3f8a87d4507f5516ad3a3afe100973d35a51cca322702dbd86f2c7c0160222 PR FY 2015 English319326
Texto indexado de https://blob.almirall.com/files/documents/160222_PR_FY_2015_English319326.pdf
almirall://content/almirall-com/c21362a0546b84037b6cc21aabc37b6bd80526e3d8ba7c2be8e49654eed9a25e1603 EN Almirall launches Solaraze in Spain for the treatment of actinic keratosis168217
Texto indexado de https://blob.almirall.com/files/documents/1603_EN_Almirall_launches_Solaraze_in_Spain_for_the_treatment_of_actinic_keratosis168217.pdf
almirall://content/almirall-com/260a221cb3f9da33ab87c66e34aefb297e9ecaa129282c1005b4096e0cbc18651607 EN Almirall colabora con la Fundacion Vicente Ferrer168236
Texto indexado de https://blob.almirall.com/files/documents/1607_EN_Almirall_colabora_con_la_Fundacion_Vicente_Ferrer168236.pdf
almirall://content/almirall-com/d187b69d94e4939274cfcd66f724fcb6b252b4eab1f2b12564142fa9af97017c1611 EN Almirall and Galapagos enter a research alliance168255
Texto indexado de https://blob.almirall.com/files/documents/1611_EN_Almirall_and_Galapagos_enter_a_research_alliance168255.pdf
almirall://content/almirall-com/c77a8d3aaec0d45b801584eb8b1a04f935290c18dc56bf5924ebfe34add6c2441612 EN NdP X Aniversario filial Mexico Feb2 English168274
Texto indexado de https://blob.almirall.com/files/documents/1612_EN_NdP_X_Aniversario_filial_Mexico_Feb2_English168274.pdf
almirall://content/almirall-com/47ffacb9ddf6f8db6dd4ca88cc772eea10f3df63cb2b0ee6d764c40e757be7131614 EN Sativex 2nd MRP announcement press release EN168293
Texto indexado de https://blob.almirall.com/files/documents/1614_EN_Sativex_2nd_MRP_announcement_press_release_EN168293.pdf
almirall://content/almirall-com/78f52044b644ebd321617460741d05ad0765bf0902219a253e0c80356b4b7b5a1617 EN Bayer and Almirall to co promote anticoagulant Rivaroxaban in Spain168321
Texto indexado de https://blob.almirall.com/files/documents/1617_EN_Bayer_and_Almirall_to_co-promote_anticoagulant_Rivaroxaban_in_Spain168321.pdf
almirall://content/almirall-com/f5c2683de690a5cbc054fc256642a0e60dd7ffab6ec7258a863e192b8f0686241620 EN Almirall licences Aclidinium for COPD to Daewoong in Korea168340
Texto indexado de https://blob.almirall.com/files/documents/1620_EN_Almirall_licences_Aclidinium_for_COPD_to_Daewoong_in_Korea168340.pdf
almirall://content/almirall-com/4797858c6b9184ff1b53540b5a66d400a214baa65b078be6dae07ff96734a4431627 EN Almirall and Forest Announce Positive FDA Advisory Committee for aclidinium168368
Texto indexado de https://blob.almirall.com/files/documents/1627_EN_Almirall_and_Forest_Announce_Positive_FDA_Advisory_Committee_for_aclidinium168368.pdf
almirall://content/almirall-com/37dae46834a92312ee5b40adb74829343812aa9a55ce0927444cfbdefabbb5861628 EN Almirall Results 2011 in line positive newsflow start to 2012168387
Texto indexado de https://blob.almirall.com/files/documents/1628_EN_Almirall_Results_2011_in_line__positive_newsflow_start_to_2012168387.pdf
almirall://content/almirall-com/f45a7a1c2eac9a80ce25cb406bbd6c7f2d664d26906de4d7189b88223b6087fe1630 EN Almirall MS Grant final168406
Texto indexado de https://blob.almirall.com/files/documents/1630_EN_Almirall_MS_Grant_final168406.pdf
almirall://content/almirall-com/5c076af0570f632c7c3b1feb05bd21a967d9cf1998fc1aac93e4d3402d511bef1632 EN Almirall extends Sativex marketing rights to Mexico168425
Texto indexado de https://blob.almirall.com/files/documents/1632_EN_Almirall_extends_Sativex_marketing_rights_to_Mexico168425.pdf
almirall://content/almirall-com/87457a29b3dc36ac681cf7efe446c0aefba6d412427920614f8ad77d11bd9a841633 EN El tratamiento personalizado de la EPOC principal reto168444
Texto indexado de https://blob.almirall.com/files/documents/1633_EN_El_tratamiento_personalizado_de_la_EPOC__principal_reto168444.pdf
almirall://content/almirall-com/54c45299d00ce4ceda6a7f8457a74a3871ca7e9c97a773bfc574013e4449cd6e1636 EN ATTAIN full publication ERJ final168463
Texto indexado de https://blob.almirall.com/files/documents/1636_EN_ATTAIN_full_publication_ERJ_final168463.pdf
almirall://content/almirall-com/3acd22a1aaef636cc514a6546cd913d0bb98781ee8ab4a18427c29afb2490d0d1638 EN Almirall and Menarini sign a commercial alliance for Aclidinium168482
Texto indexado de https://blob.almirall.com/files/documents/1638_EN_Almirall_and_Menarini_sign_a_commercial_alliance_for_Aclidinium168482.pdf
almirall://content/almirall-com/aad796bdce9b633217ba441dc2cd657828d10fef16a3c8eff568202203b828cc1639 EN Almirall and Forest Laboratories announce FDA extension for Aclidinium168501
Texto indexado de https://blob.almirall.com/files/documents/1639_EN_Almirall_and_Forest_Laboratories_announce_FDA_extension_for_Aclidinium168501.pdf
almirall://content/almirall-com/eac27f01816140234913eb5aeacf2b996f74acccd2764a68d30cfe0a325ce10b1660 EN The Almirall Annual General Meeting approves 0.18 euro pay out per share as scrip dividend168520
Texto indexado de https://blob.almirall.com/files/documents/1660_EN_The_Almirall_Annual_General_Meeting_approves_0.18_euro_pay_out_per_share_as_scrip_dividend168520.pdf
almirall://content/almirall-com/1285761a5947af46f2a21107c64eb17e6eeb238c18b0c2cc0a9ae3a9ffa9aa121661 EN 2nd MRP Day 90 ENG168539
Texto indexado de https://blob.almirall.com/files/documents/1661_EN_2nd_MRP_Day_90_ENG168539.pdf
almirall://content/almirall-com/57b9afdcc5abe35911e881bdafcc3f89b2a2de35dd930b126da9dddfb2b8aa811662 EN Almirall grows international168558
Texto indexado de https://blob.almirall.com/files/documents/1662_EN_Almirall_grows_international168558.pdf
almirall://content/almirall-com/a16b0de66173b6430f7c6bb5ced79e3f17ab3075d4e54aa66624315655c0ca6a1664 EN New strategic direction for Almirall s OD LABA168577
Texto indexado de https://blob.almirall.com/files/documents/1664_EN_New_strategic_direction_for_Almirall_s_OD_LABA168577.pdf
almirall://content/almirall-com/c7468767350b48b2bcf56da9da9c05b75ab484dbeaeac5f5c60fbcf0ef8fa07a1665 EN Almirall and Forest to Present Aclidinium Bromide Clinical Data at the ATS Annual Meeting168596
Texto indexado de https://blob.almirall.com/files/documents/1665_EN_Almirall_and_Forest_to_Present_Aclidinium_Bromide_Clinical_Data_at_the_ATS_Annual_Meeting168596.pdf
almirall://content/almirall-com/3184449233c6a559481e2e94ffdbea4a15c19ae5f3a622676d90af046579525b1669 EN Sativex starts a third PhaseIII clinical trial in CP168615
Texto indexado de https://blob.almirall.com/files/documents/1669_EN_Sativex_starts_a_third_PhaseIII_clinical_trial_in_CP168615.pdf
almirall://content/almirall-com/7f55c01d567a9976566e26caee2319f67da17a17514626aa5828d51fb63b1a561670 EN Almirall and Aslan sign a global agreement on a novel treatment for RA168634
Texto indexado de https://blob.almirall.com/files/documents/1670_EN_Almirall_and_Aslan_sign_a_global_agreement_on_a_novel_treatment_for_RA168634.pdf
almirall://content/almirall-com/dea082daab4ea26737db88e3c94026ab1d2ef1ce42d5dffa92eba2d50fe547b31671 EN Aclidinium recommended for approval in Europe final168653
Texto indexado de https://blob.almirall.com/files/documents/1671_EN_Aclidinium_recommended_for_approval_in_Europe_final168653.pdf
almirall://content/almirall-com/ab78dc2b9c4a70dc195096a46d4779bbe0fd562a09ba9dde8c655b7832dbb3cd1673 EN Almirall s OD LABA shows superiority vs indacaterol in Phase IIa final168672
Texto indexado de https://blob.almirall.com/files/documents/1673_EN_Almirall_s_OD_LABA_shows_superiority_vs_indacaterol_in_Phase_IIa_final168672.pdf
almirall://content/almirall-com/3e66cbe688d125d88ad918048e509d782aa51a5ba90581b7ee8d59a04e2cf2931684 EN Aclidinium Approval FDA EU version English168700
Texto indexado de https://blob.almirall.com/files/documents/1684_EN_Aclidinium_Approval_FDA_EU_version_English168700.pdf
almirall://content/almirall-com/13c9f04c0af7a5367150cccc239d10ebda541c0f0f617fbd6ed5d703d00c03ec1685 EN Eklira EU approval final English168719
Texto indexado de https://blob.almirall.com/files/documents/1685_EN_Eklira_EU_approval_final_English168719.pdf
almirall://content/almirall-com/7e5af51f254cf7002b487d7f1403f9973fe2cef688fc3d6a6e781b23b5e458911688 EN Almirall s H1 Strong newsflow guidance reiterated168738
Texto indexado de https://blob.almirall.com/files/documents/1688_EN_Almirall_s_H1_Strong_newsflow_guidance_reiterated168738.pdf
almirall://content/almirall-com/690c893ec40666ee15f34d4eb7c87c72bb06e696499e89bca21bf88f831bab551695 EN PR LAS39+LAS32 final 19 03168757
Texto indexado de https://blob.almirall.com/files/documents/1695_EN_PR_LAS39%2BLAS32_final_19-03168757.pdf
almirall://content/almirall-com/5c4385a6c1e7793ec07d1edf26b7503ddd047ac2e1de160c44aec401f86f65ee1698 EN Almirall obtains rights for Linaclotide in Mexico168776
Texto indexado de https://blob.almirall.com/files/documents/1698_EN_Almirall_obtains_rights_for_Linaclotide_in_Mexico168776.pdf
almirall://content/almirall-com/941c5b8d10044060ba0874a24be9c3271565d26e1bb8d4b97e7a3f016b257fc71703 EN Almirall launches Eklira Genuair aclidinium in Europe168795
Texto indexado de https://blob.almirall.com/files/documents/1703_EN_Almirall_launches_Eklira_Genuair__aclidinium__in_Europe168795.pdf
almirall://content/almirall-com/82eff8b55a270f3f5c3a8ac793b1612af7677230f7721e160dbaee60100984bb1704 EN Linaclotide receives positive CHMP opinion168814
Texto indexado de https://blob.almirall.com/files/documents/1704_EN_Linaclotide_receives_positive_CHMP_opinion168814.pdf
almirall://content/almirall-com/1cf40ab9bcd056189450b591762121641c2b351eed459858596b0a48c51083321708 EN Almirall licenses Aclidinium to Invida in Australia and New Zealand168833
Texto indexado de https://blob.almirall.com/files/documents/1708_EN_Almirall_licenses_Aclidinium_to_Invida_in_Australia_and_New_Zealand168833.pdf
almirall://content/almirall-com/b10794129b2743dc7f868a683fc7458187177d7bd2879276d8b385fdcf957a72170828 New CEO Almirall ENG1611591
Texto indexado de https://blob.almirall.com/files/documents/170828_New_CEO_Almirall_ENG1611591.pdf
almirall://content/almirall-com/9667f96a41b53cdbfa66ed98a18912a9b6f71d0ca09bac8b6a11ae09d81cc8a31709 EN Sativex confirms clinically relevant benefits in MSS168852
Texto indexado de https://blob.almirall.com/files/documents/1709_EN_Sativex_confirms_clinically_relevant_benefits_in_MSS168852.pdf
almirall://content/almirall-com/7e956bf60d7e5934b49b8bff1e62183227f7ca0e73ced7785cf463fe5f204c041710 EN Almirall incorporates Gerhard Mayr to the Board of Directors168871
Texto indexado de https://blob.almirall.com/files/documents/1710_EN_Almirall_incorporates_Gerhard_Mayr_to_the_Board_of_Directors168871.pdf
almirall://content/almirall-com/49e51a39f3290984fc795539ec88f15c08956e8057c57ab20a2d4d5fcc5f0b311711 EN Almirall invests in personalised medicine by becoming part of the share capital of AB Biotics168890
Texto indexado de https://blob.almirall.com/files/documents/1711_EN_Almirall_invests_in_personalised_medicine_by_becoming_part_of_the_share_capital_of_AB-Biotics168890.pdf
almirall://content/almirall-com/8a9df46c3fddcdf6d25676556ad5d8ad2a49db8b1c4238d99a9b0cd23d0df9bd1717 EN FINAL World COPD Day press release Pan European media 121112168909
Texto indexado de https://blob.almirall.com/files/documents/1717_EN_FINAL_World_COPD_Day_press_release_Pan_European_media_121112168909.pdf
almirall://content/almirall-com/8f44e8b306503374e4910d69b3a125d19d4f29ed123af1ea6fe69329fe7193541718 EN Q3 in line Aclidinium now available to European patients168928
Texto indexado de https://blob.almirall.com/files/documents/1718_EN_Q3_in_line__Aclidinium_now_available_to_European_patients168928.pdf
almirall://content/almirall-com/124532f74f9a112bfbb1f2bf142924eea77e4627a41f1dcd33485b58efbb3ffd1719 EN Almirall appoints Karin Dorrepaal as new independent board memeber168947
Texto indexado de https://blob.almirall.com/files/documents/1719_EN_Almirall_appoints_Karin_Dorrepaal_as_new_independent_board_memeber168947.pdf
almirall://content/almirall-com/800b5ee51968ab9b597bf12c124448d3b4e694952ca8aed8f95ea813b5cb6a7c1720 EN Constella approved in Europe final168966
Texto indexado de https://blob.almirall.com/files/documents/1720_EN_Constella_approved_in_Europe_final168966.pdf
almirall://content/almirall-com/0b472c96a3bfce6a5985e7bb9a37ddb624b84fab232215a90dc1485e9f8b17f91722 EN Tudorza Launch PR final Europe English168985
Texto indexado de https://blob.almirall.com/files/documents/1722_EN_Tudorza_Launch_PR_final_Europe_English168985.pdf
almirall://content/almirall-com/a1494ba32c11628e8d467c98855ddc54b05a1581bd1eb143b2b12576f603e0bb181112 PR 9M RESULTS ENGL3739553
Texto indexado de https://blob.almirall.com/files/documents/181112_PR_9M_RESULTS_ENGL3739553.pdf
almirall://content/almirall-com/450b5ac71b66c432141963b9815b9e2ab0fe57a4af7beba064c5486702be417a181115 PR Ilumetri launch in Germany ENG3759320
Texto indexado de https://blob.almirall.com/files/documents/181115_PR_Ilumetri_launch_in_Germany%20ENG3759320.pdf
almirall://content/almirall-com/686e9f4f9b46e38292edb24921dd09e5d85984fac4f509abc7617dce7482afe4190103 JPMorga Conference Eng4146801
Texto indexado de https://blob.almirall.com/files/documents/190103_JPMorga_Conference_Eng4146801.pdf
almirall://content/almirall-com/3f37af2f6dac6fa6f5ebf5c4dcef14bca1861d5c6e22d8807e7f528740154421190104 New Chief Digital Officer Eng4153322
Texto indexado de https://blob.almirall.com/files/documents/190104_New_Chief_Digital_Officer_Eng4153322.pdf
almirall://content/almirall-com/a87da0302524ab95621d699e1739327951cb7d571f1338e9f2bedae063fb5aa8190117 Seysara launch ROW ENG4153262
Texto indexado de https://blob.almirall.com/files/documents/190117_Seysara_launch_ROW_ENG4153262.pdf
almirall://content/almirall-com/e8b375a27ad381309c32a1f5c53fca8fa13bdbd1f402f2639697ae12654990b2190225 FY Results ENG4153005
Texto indexado de https://blob.almirall.com/files/documents/190225_FY%20Results_ENG4153005.pdf
almirall://content/almirall-com/bc67d47b902929571d9a614e3286131c12becee870c1d2a584f092b22b87cb97190225 IGC A 58869389 2018 converted1799f499 6deb 7e23 3b00 798c45fb49a4
Texto indexado de https://blob.almirall.com/files/documents_pdf/190225_IGC_A-58869389_2018_converted1799f499-6deb-7e23-3b00-798c45fb49a4.pdf
almirall://content/almirall-com/af5e61c2b418dceb604ffffd88474304af56a1e602895a737c1d09f41a78d834190304 Athenex Phase III Engl4152873
Texto indexado de https://blob.almirall.com/files/documents/190304_Athenex_Phase_III_%20Engl4152873.pdf
almirall://content/almirall-com/75924b1a4bdb49fb43cb0f86edc5043136fc6139a3bbc0f532c66ea02d67d9121905 EN Articles of association Art 31 3
Texto indexado de https://blob.almirall.com/files/2026-04/1905_EN_Articles_of_association_Art_31-3.pdf
almirall://content/almirall-com/de35c4a8a3736ce441b25ec93eaa75a4cd4c77bef14869c28b8ccd7c3ffa060d1906 EN Regulations of Annual General Meeting Art 9
Texto indexado de https://blob.almirall.com/files/2026-01/1906_EN_Regulations_of_Annual_General_Meeting_Art_9.pdf
almirall://content/almirall-com/9d745a4a02899ec179e7064abea58de8ac4d9582a55b9389f9dc25bae1de3dd21907 EN Regulations of Annual General Meeting Art 22
Texto indexado de https://blob.almirall.com/files/2026-01/1907_EN_Regulations_of_Annual_General_Meeting_Art_22.pdf
almirall://content/almirall-com/07fa0a073579e5efe6d571e4d132659f61c62a3b50ed0535dea9407a74ef2c7b191011 PR Tildrakizumab EADV4190484
Texto indexado de https://blob.almirall.com/files/documents/191011%20PR%20Tildrakizumab%20EADV4190484.pdf
almirall://content/almirall-com/e5af5590a2f155d90e3dd250b8d0e5bf90a17845061c48d7f8bb55daea280174191115 Almirall Digital Garden FH ENG4200137
Texto indexado de https://blob.almirall.com/files/documents/191115%20Almirall%20Digital%20Garden%20FH_ENG4200137.pdf
almirall://content/almirall-com/0ef369a691504f6f1e9e3d577b6ae448465f81ad7fab67cc97f427805f6e6252191212 PR Almirall Iktos ENG4472462
Texto indexado de https://blob.almirall.com/files/documents/191212%20PR%20Almirall%20Iktos_ENG4472462.pdf
almirall://content/almirall-com/74965ad689db7c5e6efcb2f7f217758e54aa045c2a65f038d4df3dee0e54835d191217 PR AlmirallShare Collaborations ENG4472476
Texto indexado de https://blob.almirall.com/files/documents/191217_PR_AlmirallShare_Collaborations_ENG4472476.pdf
almirall://content/almirall-com/487391d575217d540b15ae9b243cb5f915bbbecc9a32fdf3df662c1f109b82ef2 Anti Bribery Anti Corruption Policy 2024
Texto indexado de https://blob.almirall.com/files/2026-03/2-Anti-Bribery-Anti-Corruption-Policy-2024.pdf
almirall://content/almirall-com/8487aa3a3a5f18640ab585e53bc41fb631b5c367c88d39d0373e96d32225960920 03 25 Skin Academy Press Release6050010
Texto indexado de https://blob.almirall.com/files/documents/20_03_25_Skin%20Academy%20Press%20Release6050010.pdf
almirall://content/almirall-com/175189d2b77399f7d3a9bf18d6615eb88c8d1a8a49cd52626eed6823594ca57e20 years of the antihistamine Ebastel® (ebastine) | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/20-years-antihistamine-ebastelr-ebastine
almirall://content/almirall-com/5b11dafaae008c665256b70a8af2815ae2216375fe48e8054c44f83d70fe7e44200206 PR Almirall Plug and Play 4472915
Texto indexado de https://blob.almirall.com/files/documents/200206%20PR%20Almirall%20-%20Plug%20and%20Play_4472915.pdf
almirall://content/almirall-com/329b1e266d1757cc241c1eb19f6ebb8f666efb957f3e5df6625ef061fbc8bb1d200211 NEJM Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis FINAL EU4739161
Texto indexado de https://blob.almirall.com/files/documents/200211_NEJM_Phase%203%20Trials%20of%20Tirbanibulin%20Ointment%20for%20Actinic%20Keratosis_FINAL%20EU4739161.pdf
almirall://content/almirall-com/5b79fc7435b170a5eec5604a61ff5512bdd1940c140c743e9f8c73bc0291beed20022020 Financial Results 2019 English4382788
Texto indexado de https://blob.almirall.com/files/documents/20022020%20Financial%20Results%202019_English4382788.pdf
almirall://content/almirall-com/39f5d07554b0e371129a50bd7ec64fc4688fad8ba6495834dba926608660d09f200302 PR tirba filing EMA ALM4382726
Texto indexado de https://blob.almirall.com/files/documents/200302_PR_tirba_filing%20EMA_ALM4382726.pdf
almirall://content/almirall-com/7bf544dbf549b7410d365e50aacb88d2ea52642d06b8966a3201945e45aa75e4200309 PR ALMIRALL tirba filing US4410005
Texto indexado de https://blob.almirall.com/files/documents/200309_PR%20ALMIRALL_tirba_filing%20US4410005.pdf
almirall://content/almirall-com/d29ced1eef917e468efff99e52dccfd436c70cf29d90b5020d106b398fea6eec200327 NdP Donaciones COVID19 ENG4389219
Texto indexado de https://blob.almirall.com/files/documents/200327_NdP_Donaciones%20COVID19_ENG4389219.pdf
almirall://content/almirall-com/cfff8bff6d3a6f2fed611aca10800614bded012a26bc8dabcc64d5fb1f9675f2200527 PR TRIDS4DEB ENG 4457558
Texto indexado de https://blob.almirall.com/files/documents/200527_PR_TRIDS4DEB_ENG_4457558.pdf
almirall://content/almirall-com/c66ff2c3c52c6460ac9beed8c9b060ff9acc448e68d959e1ef6235736a302c14201016 PR second call Digital Garden ENG4633338
Texto indexado de https://blob.almirall.com/files/documents/201016_PR_second%20call%20Digital%20Garden_ENG4633338.pdf
almirall://content/almirall-com/fb43013690d17c0edf2e72491dd0c05d325d8facc75a7e8c4dd18e789a329b98201130 PR Call Digital Garden ENG4682812
Texto indexado de https://blob.almirall.com/files/documents/201130_PR_Call%20Digital%20Garden_ENG4682812.pdf
almirall://content/almirall-com/58fae8ff0a7d4dffeec53aa83aa66ce79e5c6d08555f3a1780501aed06bb4d9f2012 CDP report web ENG4715320
Texto indexado de https://blob.almirall.com/files/documents/2012_CDP%20report_web_ENG4715320.pdf
almirall://content/almirall-com/c94be920a927c1cc625064ec9fda6f44cbd8378972bc5c493453e851ba6e455e2012 results in line with guidance; positioning Almirall for transformative growth from 2013 | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/2012-results-line-guidance-positioning-almirall-transformative-growth-2013
almirall://content/almirall-com/7f73e5ca6a9c795b382adb8b73d3a14de15f081303920665fce06fa9ea887f2d20131812 NDP English177569
Texto indexado de https://blob.almirall.com/files/documents/20131812_NDP_English177569.pdf
almirall://content/almirall-com/b8518ada806da4a30eb20ae321ceb9045446575027a77f61cb05826874a39ec12014 02 23 FY Results 2013 EN198043
Texto indexado de https://blob.almirall.com/files/documents/2014%2002%2023%20FY%20Results%202013%20EN198043.pdf
almirall://content/almirall-com/51e664e94774ca730909c1e88533f51c52bbff6be2e0260f6e7ca98dad1c29a92014 03 19 Precio Deuda ENGLISH200440
Texto indexado de https://blob.almirall.com/files/documents/2014%2003%2019%20Precio%20Deuda%20ENGLISH200440.pdf
almirall://content/almirall-com/0304233142ad464e066a4c7130d9b195be1b3f2c10864bbdc33421dcb607e6842014 04 01 Eng Pressrelease InDex Almirall Kappaproct DEF201125
Texto indexado de https://blob.almirall.com/files/documents/2014%2004%2001_Eng_Pressrelease%20InDex%20Almirall%20Kappaproct%20DEF201125.pdf
almirall://content/almirall-com/8e69d7f070908f1ef2fbe3ff8ea4582df23ee064643ff8eff188bdade32b95d92014 04 08 Press Release Status FDA Feedback ENG201565
Texto indexado de https://blob.almirall.com/files/documents/2014%2004%2008%20Press%20Release%20Status%20FDA%20Feedback%20ENG201565.pdf
almirall://content/almirall-com/0489fd7f4bef4939009b38e6bbf5824a2c95877662336aa5ca1659288fe2c7a82014 05 11 Q1 Results 2014 EN202802
Texto indexado de https://blob.almirall.com/files/documents/2014%2005%2011%20Q1%20Results%202014%20EN202802.pdf
almirall://content/almirall-com/32f30437a1a86eb3b51706a83da838e3156b8fd4093837e841c7b2b46432d41e2014 07 28 Press Release ALM English221326
Texto indexado de https://blob.almirall.com/files/documents/2014%2007%2028%20Press%20Release%20ALM%20English221326.pdf
almirall://content/almirall-com/75aa8837af2f4a4ec8e3ba4720b056cbc0327f88bb0fc2bea74e3cfe5b2c35e52014 07 29 H1 Results 2014 EN221130
Texto indexado de https://blob.almirall.com/files/documents/2014%2007%2029%20H1%20Results%202014%20EN221130.pdf
almirall://content/almirall-com/fff963e32cf2708fedf51af0f9f503e30408637a3cda9aea7cf55a14632a6eae2014 10 22 ALMIRALL FINALIZA EL ACUERDO CON ASTRAZENECA EN EL AREA RESPIRATORIA255804
Texto indexado de https://blob.almirall.com/files/documents/2014%2010%2022%20ALMIRALL%20FINALIZA%20EL%20ACUERDO%20CON%20ASTRAZENECA%20EN%20EL%20AREA%20RESPIRATORIA255804.pdf
almirall://content/almirall-com/d5af8eb8e8da0eeed70d24e6c3c50e0cc2395a8ad836b0feee519f92bec9ace12015 02 23 Financial Results FY 2014 Final282279
Texto indexado de https://blob.almirall.com/files/documents/2015%2002%2023%20Financial%20Results%20FY%202014%20Final282279.pdf
almirall://content/almirall-com/0a750659d3bb0af9a6e47710f650b274e6913f4a7a4cc7f95fe1be24ea73d43d2015 05 08 Financial Results Q1 FY2015 ENG Final295832
Texto indexado de https://blob.almirall.com/files/documents/2015%2005%2008%20Financial%20Results%20Q1%20FY2015%20ENG%20Final295832.pdf
almirall://content/almirall-com/5a49a84350a47e292dc469b82f9dee21c113c1a7df1678767b0f17aa2e7cfb942015 07 27 Financial Results H1 EN306607
Texto indexado de https://blob.almirall.com/files/documents/2015%2007%2027%20Financial%20Results%20H1%20EN306607.pdf
almirall://content/almirall-com/ce1fcb60e14bda2845975960278bb3057f6bb5efe6bd161d010a65c84ebaaf842015 07 29 Almirall PR EN retocada306826
Texto indexado de https://blob.almirall.com/files/documents/2015%2007%2029%20Almirall%20PR%20EN%20retocada306826.pdf
almirall://content/almirall-com/c882f0052c29b7eef1126102d2881cf11980026a44f34ce01215e410d285ff142015 11 09 Financial Results Q3 EN Final312374
Texto indexado de https://blob.almirall.com/files/documents/2015%2011%2009%20Financial%20Results%20Q3%20EN%20Final312374.pdf
almirall://content/almirall-com/2da572d2f13928f4add5b60170eae9b6fddb42eed0e2e7de2ea8f1d39051a2d52015 11 23 Almirall PR Toctino ENG Final313726
Texto indexado de https://blob.almirall.com/files/documents/2015%2011%2023%20Almirall%20PR%20Toctino_ENG_Final313726.pdf
almirall://content/almirall-com/796c80376629916dc2365fb0294cc2c0dc8909c73f7f1efd644b2ef9f324326c2015 11 30 NP Polichem EN v2313941
Texto indexado de https://blob.almirall.com/files/documents/2015%2011%2030%20NP%20Polichem%20EN_v2313941.pdf
almirall://content/almirall-com/8af86aaf4476af33119b3c4e9a3ca1a3afe04e075d1ae70d6d6b7338308bc61a20150 23 Duaklir recommended for approval in Europe FINAL227748
Texto indexado de https://blob.almirall.com/files/documents/20150%2023%20Duaklir%20recommended%20for%20approval%20in%20Europe%20FINAL227748.pdf
almirall://content/almirall-com/e78ec7781209b13a6005dabe45e922949a718774ea5ae24402b577851fa68e5a2016 01 01 PR TEA EN316063
Texto indexado de https://blob.almirall.com/files/documents/2016%2001%2001%20PR%20TEA%20EN316063.pdf
almirall://content/almirall-com/7fcc9d5c0fb361062caf335e3e743a04f06fefeae8258d9022339197d375b4fd20160205 PRAlmirall closes deal to acquire ThermiGen LLC318673
Texto indexado de https://blob.almirall.com/files/documents/20160205_PRAlmirall_closes_deal_to_acquire_ThermiGen%20LLC318673.pdf
almirall://content/almirall-com/0a809a5c24da972ce6ca0435fd9267b12f3d2dcba6cf16c3a8263406ec7ff1b020160224 PR Almirall reduces its accident rate by 69 in Spain in 2015 DF319734
Texto indexado de https://blob.almirall.com/files/documents/20160224_PR_Almirall_reduces_its_accident_rate_by_69_in_Spain_in_2015_DF319734.pdf
almirall://content/almirall-com/e8e9f68772385592b849aeae90cd02d0f350d18701d9c9cf90341298291c875420160504 PR Castellano342494
Texto indexado de https://blob.almirall.com/files/documents/20160504_PR_Castellano342494.pdf
almirall://content/almirall-com/eb422c5a1d9fbf643974895061df1ec16ed310c77e26265336f700c79859124420160726 PR H1 2016 English363447
Texto indexado de https://blob.almirall.com/files/documents/20160726_PR_H1_2016_English363447.pdf
almirall://content/almirall-com/1fa74a383a94f16ea2531cd03850a586c670db2782ba7ca38fdd8c6769ff465820161018 PR Almirall announces a restructuring plan in Spain626703
Texto indexado de https://blob.almirall.com/files/documents/20161018_PR_Almirall_announces_a_restructuring_plan_in_Spain626703.pdf
almirall://content/almirall-com/935ad4cfa6982f9ed2252ceaddacff45dba33bee61b2376fec4fb38821a3120f20161209 NUE ALM ENG768251
Texto indexado de https://blob.almirall.com/files/documents/20161209_NUE-ALM_ENG768251.pdf
almirall://content/almirall-com/db492ad6739fcc9490533b2d419c000e66438cea4234b383f2f68d2f9eb29ebc20161219 PRMercachem ALM ESP783144
Texto indexado de https://blob.almirall.com/files/documents/20161219_PRMercachem-ALM_ESP783144.pdf
almirall://content/almirall-com/95b3fb0322c10df8d10edbf182df3d839b580e8723f773d4627f08608aceed6b2017 03 03 Press Release Tildrakizumab 2017 American Academy of Dermatology Meeting858888
Texto indexado de https://blob.almirall.com/files/documents/2017%2003%2003%20Press%20Release%20Tildrakizumab%202017%20American%20Academy%20of%20Dermatology%20Meeting858888.pdf
almirall://content/almirall-com/5267e5626fc0002fa03d413c28826403e3452122a51fe4a818dad3b5dd7e349020170224 PN Eng809430
Texto indexado de https://blob.almirall.com/files/documents/20170224_PN_Eng809430.pdf
almirall://content/almirall-com/0a72c766aceed27a8b7afca315d78f2ef383b2b988a05e06790df08d972b4a5620170505 ResultadosQ1 ENGLISH FINAL1206161
Texto indexado de https://blob.almirall.com/files/documents/20170505_ResultadosQ1_ENGLISH_FINAL1206161.pdf
almirall://content/almirall-com/711a52804323227fbc40b7cd73f06efacf0c04e712bf11c172644ef34e7d2da220170710 PR Almiralls Guidance Update 2017 EN1491819
Texto indexado de https://blob.almirall.com/files/documents/20170710_PR_Almiralls_Guidance_Update_2017_EN1491819.pdf
almirall://content/almirall-com/1d56c5a55e6ad19a9f45c5698bc36cf1b99e5fff25466d3a1e09ed379fa6567820170718 PR Nano4Derm Collaboration ENG Revfinal1558506
Texto indexado de https://blob.almirall.com/files/documents/20170718_PR_Nano4Derm_Collaboration_ENG_Revfinal1558506.pdf
almirall://content/almirall-com/41937ec8f3efb524a5d929a1683e1993ec33d01b80bd4cbd701d6f093bea558420170724 PR Almiralls H1 results ENG1583865
Texto indexado de https://blob.almirall.com/files/documents/20170724_PR_Almiralls_H1_results_ENG1583865.pdf
almirall://content/almirall-com/d3860d067840f9513f2e57b881b6fedd0dacc6bd619edb937902b515b5832a3120170906 Almirall AMPLIFY Phase III Results EN1613038
Texto indexado de https://blob.almirall.com/files/documents/20170906_Almirall_AMPLIFY_Phase_III_Results_EN1613038.pdf
almirall://content/almirall-com/3286de5dd509dc7e7a0d80fb475dd1fdba228e9870e7ffaddc31ee9c975162de20170913 PR New Corporate Identity Almirall ENG1620579
Texto indexado de https://blob.almirall.com/files/documents/20170913_PR_New_Corporate_Identity_Almirall_ENG1620579.pdf
almirall://content/almirall-com/d31b692960d565056ed66656940ca9d36d6c270b92eb54c25979ffe145fe952420170914 PR Skilarence Launch NICE ENG1631274
Texto indexado de https://blob.almirall.com/files/documents/20170914_PR_Skilarence_Launch_NICE_ENG1631274.pdf
almirall://content/almirall-com/7174f0d0d7bcfa0213e25e648715c26024288b03f2003268d4e0613f3e614df320171027 PR Sativex SAVANT Trial ENG1887101
Texto indexado de https://blob.almirall.com/files/documents/20171027_PR_Sativex_SAVANT_Trial_ENG1887101.pdf
almirall://content/almirall-com/9a914aeedee4e5ddcd0d00a6ca0c58158f3ef7625a036fd3c9bae8ef1bfb800520171103 PR Almirall Q3 results ENG1934341
Texto indexado de https://blob.almirall.com/files/documents/20171103_PR_Almirall_Q3_results_ENG1934341.pdf
almirall://content/almirall-com/6f56196c734c4409cb2d63317a3a5ddf1e1ddcd6b45d2223048104d0d6a1ca4320171204 PhaseIV ASCENT Tudorza ENG2090357
Texto indexado de https://blob.almirall.com/files/documents/20171204_PhaseIV_ASCENT_Tudorza_ENG2090357.pdf
almirall://content/almirall-com/e480bfd8c28b31fc2cb976e03d88e94e8c469e6047a339a9a414b9a3a84f7df320171211 PR ATNX Almirall ENG2132320
Texto indexado de https://blob.almirall.com/files/documents/20171211_PR_ATNX_Almirall_ENG2132320.pdf
almirall://content/almirall-com/2aabb420658bf6748e12ff38deb2e6052362e116d8ef3a2ee64cb188a79e2e1e2018 02 22 PR Thermi Sinclair2486625
Texto indexado de https://blob.almirall.com/files/documents/2018_02_22_PR_Thermi_Sinclair2486625.pdf
almirall://content/almirall-com/88cd4781ff596716c2de9fe5d9613092ae682d5b700b5dc95f5d88cf6fbc302d2018 02 23 PR Almirall Annual Results ENG2496061
Texto indexado de https://blob.almirall.com/files/documents/2018_02_23_PR_Almirall_Annual_Results_ENG2496061.pdf
almirall://content/almirall-com/7ceb05038249d85a8bcb75ae6e7828deb8c2d36d6fb38642d7581769ba8470762018 05 14 PR Almirall Q1 2018 results ENG2874905
Texto indexado de https://blob.almirall.com/files/documents/2018_05_14_PR_Almirall_Q1_2018_results_ENG2874905.pdf
almirall://content/almirall-com/6c48d54e5bb470e00be6272c177dbb1c7f8402fea045246dcc116dabcf5a12612018 06 04 THVIV Final PR2985122
Texto indexado de https://blob.almirall.com/files/documents/2018_06_04_THVIV_Final_PR2985122.pdf
almirall://content/almirall-com/1fb8203ef8595b327ab48d938feda582b03b1d48a3283211b19b16a52964fc492018 07 26 PR Phase III KX 391 ENG FINAL3223229
Texto indexado de https://blob.almirall.com/files/documents/2018_07_26_PR_Phase_III_KX-391_ENG_FINAL3223229.pdf
almirall://content/almirall-com/ac4785844a70dc97d97bcc1d06a2e66d0dabb191cdf260d27c1cba446e6a58682018 07 27 PR CHMP tildrakizumab ENG3229603
Texto indexado de https://blob.almirall.com/files/documents/2018_07_27_PR_CHMP_tildrakizumab_ENG3229603.pdf
almirall://content/almirall-com/9657974d7849dcf43f5378162b3760f9a8d5960f6d4024e071cbdcb20cd629e52018 07 30 PR Almirall H1 2018 results ENG3237830
Texto indexado de https://blob.almirall.com/files/documents/2018_07_30_PR_Almirall_H1_2018_results_ENG3237830.pdf
almirall://content/almirall-com/d857fe99c9bcdd519c90d824b250637cb765e22359fa888635d5d2d75dfdcce52018 08 03 PR ALM Acquisition portfolio Allergan ENG3261397
Texto indexado de https://blob.almirall.com/files/documents/2018_08_03_PR_ALM_%20Acquisition_portfolio_Allergan_ENG3261397.pdf
almirall://content/almirall-com/aa08082ec92e45f196cb07399ee3e30684b36060c0f2254f3b9caf0861fd8e7e20180918 PR EMA tildrakizumab ENG3468024
Texto indexado de https://blob.almirall.com/files/documents/20180918_PR_EMA_tildrakizumab_ENG3468024.pdf
almirall://content/almirall-com/a19f123b2b51c8f44df242cea12113825a03fda49c6bac4c6f732e397698ccf520180921 PR ALM Closing of Allergan Agreement ENG 3486092
Texto indexado de https://blob.almirall.com/files/documents/20180921_PR_ALM_%20Closing_of_Allergan_Agreement_ENG_3486092.pdf
almirall://content/almirall-com/e6a43f6cb63f9e2ca7f73ba0d9b5f166b493c937ad42aa41ce7559a0e5add37920181002 PR FDA APPROVAL SEYSARA ENG final3540239
Texto indexado de https://blob.almirall.com/files/documents/20181002_PR_FDA%20APPROVAL_SEYSARA_ENG_final3540239.pdf
almirall://content/almirall-com/ac2a92a50e83faf8273fb449a379606735c2508da780438543b55ad6edc2ab4d20181204 ALM ENG PR Bonds club deal Launch LL3849984
Texto indexado de https://blob.almirall.com/files/documents/20181204_ALM_ENG_PR_Bonds_club_deal_Launch_LL3849984.pdf
almirall://content/almirall-com/695be00ad6f52801e697c57ecf72ba33ad6d287ec8ddca234359ed41c8dda34620181204 ALM ENG PR Bonds pricing LL3853339
Texto indexado de https://blob.almirall.com/files/documents/20181204_ALM_ENG_PR_Bonds_pricing_LL3853339.pdf
almirall://content/almirall-com/69c789202acc796758c9168a6cf2686da68dd3353fd3570df80dc54dc493e0632019 03 25 Almirall HitGen DEL Screening Press Release AB EN4152791
Texto indexado de https://blob.almirall.com/files/documents/2019_03_25_Almirall_HitGen_DEL_Screening_Press_Release_AB_EN4152791.pdf
almirall://content/almirall-com/26d94e097f7e4f14d561ef42922120a15abebe035dfba028e3bd163537d9d7ee2019 10 04 PR Digital Garden Almirall in BHH Summit ENG4183936
Texto indexado de https://blob.almirall.com/files/documents/2019%2010%2004_PR_Digital%20Garden%20Almirall%20in%20BHH%20Summit_ENG4183936.pdf
almirall://content/almirall-com/087c44542a8ca8529dda05e4add919ea7bde6a8aba78e9612fe851577562ba5d20190204 Athenex Phase III Engl4153199
Texto indexado de https://blob.almirall.com/files/documents/20190204_Athenex_Phase_III_Engl4153199.pdf
almirall://content/almirall-com/06b4c2f96b38d6e2dc003817939974c43f4fee949818d8d702f64f7dc64581e920190208 Results 2018 AlmirallShare ENG4153130
Texto indexado de https://blob.almirall.com/files/documents/20190208_Results_2018_AlmirallShare_ENG4153130.pdf
almirall://content/almirall-com/ebbd333829fd1f9c3ebb89ba7562765a4ed000d912a9f64851f3ef6ce1488caf20190211 Dermira Eng final Vs4153084
Texto indexado de https://blob.almirall.com/files/documents/20190211_Dermira_Eng_final_Vs4153084.pdf
almirall://content/almirall-com/2d75987b52da5edcd780ac274999b8f99a748dacdef463ab0b594bbe7a5c867020190226 PR Almirall and Nuevolution ENG PC4152930
Texto indexado de https://blob.almirall.com/files/documents/20190226_PR_Almirall_and_Nuevolution_ENG_PC4152930.pdf
almirall://content/almirall-com/f87d3921a9a00d97280908419d71098f99a5d923c1c84696c0562d9907fa7c0520190308 PR Ilumetri NICE ENG4152838
Texto indexado de https://blob.almirall.com/files/documents/20190308_PR_Ilumetri_NICE_ENG4152838.pdf
almirall://content/almirall-com/a7cfef038f4d0ab479a1e5c92c6c57c286418b422be07c7a77e58d032f3bb6cb20190401 FDA approval Duaklir Tudorza ENG4152745
Texto indexado de https://blob.almirall.com/files/documents/20190401_FDA_approval_Duaklir_Tudorza_ENG4152745.pdf
almirall://content/almirall-com/061be4e983f61dccd679bc06fd4afb1bd6b42affbf54e91ac414f231dfa8903b20190417 PR ILUMETRI definitive NICE ENG Lau4152653
Texto indexado de https://blob.almirall.com/files/documents/20190417_PR%20ILUMETRI_definitive_NICE_ENG_Lau4152653.pdf
almirall://content/almirall-com/85dd1bc0cd2cd9d31c32c6dd81569420609d278f1eee988527c9e166806cc4f720190513 PR Almirall Q1 2019 results ENG4152559
Texto indexado de https://blob.almirall.com/files/documents/20190513_PR_Almirall_Q1_2019_results_ENG4152559.pdf
almirall://content/almirall-com/361e8c554f9afdee10aaa4c6011f53b71dfdbe168c78a6087758081563a8876220190625 Almirall PR ENG4144029
Texto indexado de https://blob.almirall.com/files/documents/20190625_Almirall_PR_ENG4144029.pdf
almirall://content/almirall-com/98fb7354bfc1948d7234e706a260d6af979e8c9c4b3931a2d55a1320755b735e20190702 NdP Almiral ISO Acreditations ENG4152146
Texto indexado de https://blob.almirall.com/files/documents/20190702_NdP_Almiral_ISO_Acreditations_ENG4152146.pdf
almirall://content/almirall-com/0433ef39134c3880d59c36286b91c82476c8aeff5cb1a8759c662a580ecc783f20190812 PR Ilumetri Scotland ENG definitive4175459
Texto indexado de https://blob.almirall.com/files/documents/20190812_PR%20Ilumetri_Scotland_ENG_definitive4175459.pdf
almirall://content/almirall-com/3920d7948f2231ebb168f1730f6f2b049ec13913bec23269aa164ecfd57606e420190916 PR ALM AnnouncementCFO ENG4179522
Texto indexado de https://blob.almirall.com/files/documents/20190916_PR_ALM_%20AnnouncementCFO_ENG4179522.pdf
almirall://content/almirall-com/45016e633406d9bbf767197fbd34fd5c49ea137a398ad79a49f977e7426278be20191021 CORP Milestone Duaklir ENG4192955
Texto indexado de https://blob.almirall.com/files/documents/20191021_CORP_Milestone%20Duaklir_ENG4192955.pdf
almirall://content/almirall-com/e8cd2d0edcda0585a0d800ba7c0d7cf546f2ae93b9d02f468dfd795a22a5d1e720191111 Financial Results Q34198442
Texto indexado de https://blob.almirall.com/files/documents/20191111_Financial%20Results%20Q34198442.pdf
almirall://content/almirall-com/0ca409484eacd06d76b57753e5348aef276c538bfcfab3ff45ec7c58e805c61c20191112 CORP CMO appointment Eng4214096
Texto indexado de https://blob.almirall.com/files/documents/20191112_CORP_CMO%20appointment_Eng4214096.pdf
almirall://content/almirall-com/8bbc2f733b7d28b954f429ab66d21f97cd8a8130359e112f473d0d79ada6bcfb20200108 PR Almirall Bioniz ENG4472852
Texto indexado de https://blob.almirall.com/files/documents/20200108_PR_Almirall-Bioniz_ENG4472852.pdf
almirall://content/almirall-com/0e0305184920ae76c97e7fed25b2773d90f6699fa46d9257accdcf2eeca06e6120200109 CORP Almirall and Wuxi Collaboration Agreement ENG4472570
Texto indexado de https://blob.almirall.com/files/documents/20200109_CORP_Almirall%20and%20Wuxi%20Collaboration%20Agreement_ENG4472570.pdf
almirall://content/almirall-com/1710fc2fe0fb0b1b7df0e0bd8d763ca7c3b28cc8b18dae9044a615872bb4a33d20200109 PR Almirall 23andme ENG4472599
Texto indexado de https://blob.almirall.com/files/documents/20200109_PR_Almirall-23andme_ENG4472599.pdf
almirall://content/almirall-com/d5259ff7180f22b720a7b902ceb9b1fa9c39d64d3db620df6ed2bb53255f0a7320200115 JPMorgan Conference Eng4472866
Texto indexado de https://blob.almirall.com/files/documents/20200115_JPMorgan%20Conference_Eng4472866.pdf
almirall://content/almirall-com/6b21b3080617542eebe8c89d41385ecb61450f9028dc534c9ab3cb411167466520200221 PR Seysara ENG4382659
Texto indexado de https://blob.almirall.com/files/documents/20200221_PR_Seysara_ENG4382659.pdf
almirall://content/almirall-com/fd1e9074909bd38bc1c714a3863e0064520193feb78b34794fda09727b4235ac20200511 PR Almirall Q1 2020 results ENG final4442892
Texto indexado de https://blob.almirall.com/files/documents/20200511%20PR%20Almirall%20Q1%202020_results_ENG_final4442892.pdf
almirall://content/almirall-com/5fee8c34aa138a9b92db0645d72aafadf8d29e5405cd26ad3b22b2af4d65d24320200608 e MS Summit ENG4468638
Texto indexado de https://blob.almirall.com/files/documents/20200608_e-MS%20Summit_ENG4468638.pdf
almirall://content/almirall-com/7330775244a9d3e43aed223bd519490f513cd91bedadb17353569a7b7510f1ed20200611 CORP IBEX 35 ENG4471815
Texto indexado de https://blob.almirall.com/files/documents/20200611_CORP_IBEX%2035_ENG4471815.pdf
almirall://content/almirall-com/062666830c5ab7c2d0998d1743d29da52f4be03b3b0f8be5ad4938ba4efe45be20200721 CORP AMR Fund ENG4519491
Texto indexado de https://blob.almirall.com/files/documents/20200721_CORP_AMR%20Fund_ENG4519491.pdf
almirall://content/almirall-com/c82c7658695c67c037099485ef2c3f34bba4cb70f8c1b763d14e21505f9b5efd20200727 CORP HY 2020 ENG4533028
Texto indexado de https://blob.almirall.com/files/documents/20200727_CORP_HY%202020_ENG4533028.pdf
almirall://content/almirall-com/20f27c9b6dd61065339b3eec1db1a95d7a6cf9c63d2f8aaa4d1e7f3e880d79df20200928 Peter Guenter ENG4606542
Texto indexado de https://blob.almirall.com/files/documents/20200928_Peter%20Guenter_ENG4606542.pdf
almirall://content/almirall-com/06571049ff1821fa9b3beaa7c449545311bf4544d8d8736b66072e9f7250bd8620201008 PR Almirall Dundee4626717
Texto indexado de https://blob.almirall.com/files/documents/20201008_%20PR%20Almirall%20Dundee4626717.pdf
almirall://content/almirall-com/42ed62b20c6298c530bfa920fe1d4cdcee279104b2db52a7684bee955ef5aa9720201031 ILUMETRI Tildrakizumab5Y EADV ENG4655649
Texto indexado de https://blob.almirall.com/files/documents/20201031_ILUMETRI_Tildrakizumab5Y_EADV%20_ENG4655649.pdf
almirall://content/almirall-com/d917e4af1cca864fa864d8d2bb460c1f1bc05482785e582b798e61a511e8117620201103 CORP Q3 RESULTS 2020 ENG4663459
Texto indexado de https://blob.almirall.com/files/documents/20201103_CORP_Q3%20RESULTS%202020_ENG4663459.pdf
almirall://content/almirall-com/5074bbe55fac27d21240b0a708303171b830edbd8bf57623b5a7c856af7fc20020201112 Popit Almirall PR ENG (1)4666284
Texto indexado de https://blob.almirall.com/files/documents/20201112_Popit_Almirall%20PR_ENG%20(1)4666284.pdf
almirall://content/almirall-com/1d879d0b48f9c6b7dcfd9fbe63dc75bd1ab278f88aebf04b955748a39a726a5f20201124 PR AlmirallShare New collaborations final4675497
Texto indexado de https://blob.almirall.com/files/documents/20201124_PR_AlmirallShare_New%20collaborations_%20final4675497.pdf
almirall://content/almirall-com/b00e99982fef2ccacab6b69b18f0a882aacaf5f67bf76a27917b61c6023c37d72020xxxx Almirall PR FRANCE Ilumetri ENG4630572
Texto indexado de https://blob.almirall.com/files/documents/2020xxxx_Almirall%20PR%20FRANCE_Ilumetri_ENG4630572.pdf
almirall://content/almirall-com/9ea8cacf104c124a3e4ee4a9eb2741fbec0155afc19e5b05de92d6cce1d806fb2021 2024 Equality Plan Almirall
Texto indexado de https://blob.almirall.com/files/2026-01/2021%202024%20Equality%20Plan%20Almirall.pdf
almirall://content/almirall-com/99784f711bf77ca24c93c462413da50a1059b3cba0411811bcdec7c7762ca79620210203 CEO Announcement4732127
Texto indexado de https://blob.almirall.com/files/documents/20210203_%20CEO%20Announcement4732127.pdf
almirall://content/almirall-com/bb363add0417c7442a45067e7766ab8ffc132295b59faa7bac4a2a5ae040743620210217 MC2 ALM PR4743507
Texto indexado de https://blob.almirall.com/files/documents/20210217_MC2-%20ALM%20PR4743507.pdf
almirall://content/almirall-com/8bf6ecf19d01c7869b9143f2899205c03f6111f139786cd5d67f897e9876c52120210505 Profarma2020 ENG4810731
Texto indexado de https://blob.almirall.com/files/documents/20210505_Profarma2020_ENG4810731.pdf
almirall://content/almirall-com/ab95835becfdad7e88f4ba3bd9d819bb9dda4a2df857af5a9970a0e7dbe78bc520210510 Almirall Q1 RESULTS 2021 ENG DEF4815011
Texto indexado de https://blob.almirall.com/files/documents/20210510_Almirall_Q1%20RESULTS%202021_ENG_DEF4815011.pdf
almirall://content/almirall-com/1364eb2fb7769dc01bea8133c04aca6576dd038b3323c77d89e59ff171337b2c20220509 PR Q1RESULTS2022 ENG5149332
Texto indexado de https://blob.almirall.com/files/documents/20220509_PR_Q1RESULTS2022_ENG5149332.pdf
almirall://content/almirall-com/45f7ecef9c13548d115c3aff4a920e9fa25de94e4efe29cd52c7f9a567b453df2022f16ecp1 SCIIF
Texto indexado de https://blob.almirall.com/files/2026-03/2022f16ecp1-SCIIF.pdf
almirall://content/almirall-com/7651b75a5e9065f602d97ae5ee2d5572a699f7936c588836520a1e13bbf9e6302023 SPAIN POs.pdf
Texto indexado de https://blob.almirall.com/files/2026-04/2023_SPAIN_POs.pdf.pdf
almirall://content/almirall-com/14ccabf7fc1c73ad909b920b0458c5fde4198036f529e862c0c3be9457f6b50620230609 Grandchild Informe de administradores ABO y exclusion DSP 2
Texto indexado de https://blob.almirall.com/files/2026-04/20230609-Grandchild-Informe-de-administradores-ABO-y-exclusion-DSP-2.pdf
almirall://content/almirall-com/f7da89512eee984538f4cc9c16be181aad0ee577db0ee0fe2c764b0ef5773f5720230612 Grandchild Launch Press Release (Equity) ENG5494429
Texto indexado de https://blob.almirall.com/files/documents/20230612%20Grandchild%20-%20Launch%20Press%20Release%20(Equity)%20ENG5494429.pdf
almirall://content/almirall-com/77605df014d0538cbdb075247333252f49a143c3fee1a420a02a16537a489f6c20230613 Grandchild Pricing Press Release (Equity) ENG v25495159
Texto indexado de https://blob.almirall.com/files/documents/20230613%20Grandchild%20-%20Pricing%20Press%20Release%20(Equity)%20ENG%20v25495159.pdf
almirall://content/almirall-com/3a5b1ebc75d3176cb836072996eb9549780125fe3a8dac888b31e24cc023a1fa20240610 Klisyri LargeFieldPressRelease EU Final5803107
Texto indexado de https://blob.almirall.com/files/documents/20240610_Klisyri_LargeFieldPressRelease_EU%20Final5803107.pdf
almirall://content/almirall-com/a666acc2e8d1ca9e6c2114b818f82572fe3029153d464890d33cb73fbf00c9ee2025 Energy Efficiency annual report
Texto indexado de https://blob.almirall.com/files/2026-07/2025-Energy-Efficiency-annual-report.pdf
almirall://content/almirall-com/395fa25b3565d826488597e58d1514a7168e618b6e8b2fb4fbfeafcb2329317c2025 results PR 23 02 26 FINAL6331481
Texto indexado de https://blob.almirall.com/files/documents/2025-results-PR-23-02-26_FINAL6331481.pdf
almirall://content/almirall-com/a8f2f411cc61ee83de4a2351ab5626d6fcb95385c935f470d56bf6057ec666952025 Year In Review: Entering An Era Of Sustained Growth | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/2025-year-review-entering-era-sustained-growth
almirall://content/almirall-com/98b10d976af541e216a3cf8657e4343e2bd84733699d6ed4e4134150dcd4b47720250221 Almirall IAGC 2024
Texto indexado de https://blob.almirall.com/files/2026-03/20250221-Almirall-IAGC-2024.pdf
almirall://content/almirall-com/aae767e49c5aa9458602b17cb7d27cc2355976ef30485df8c697eccb7139ac3c20250221 Almirall IARC 2024 3
Texto indexado de https://blob.almirall.com/files/2026-03/20250221-Almirall-IARC-2024-3.pdf
almirall://content/almirall-com/d836d8c73c5f3420a66c78e34ef65729c5f429e2d77066d05c75be950ec2703c2026 05 08 AGM Regulations ENG v def
Texto indexado de https://blob.almirall.com/files/2026-07/2026-05-08_AGM-Regulations-ENG-v-def.pdf
almirall://content/almirall-com/084bba08ec68debc36c985ff1a6453ca6843064aa7dee4f2e9276d3a6a9d08872026 Top Employer Spain Germany all operational sites
Texto indexado de https://blob.almirall.com/files/2026-07/2026-Top-Employer-Spain-Germany-all-operational-sites.pdf
almirall://content/almirall-com/1604c43a76d0895112fd02cb7ee44a03a7f4a30d209eceb382613f01adfe584220260511 Almirall OIR Rectificacion PreCor Documento informativo ENG
Texto indexado de https://blob.almirall.com/files/2026-05/20260511-Almirall-OIR-Rectificacion-PreCor-Documento-informativo-ENG.pdf
almirall://content/almirall-com/c0493a8b2d176722e3e949d2d2e2f5f73216b41a821c5efa7b39166b1808949a20260604 Almirall OIR Resultado aumento y ejercicio compra ENG
Texto indexado de https://blob.almirall.com/files/2026-06/20260604-Almirall-OIR-Resultado-aumento-y-ejercicio-compra-ENG.pdf
almirall://content/almirall-com/f12be1d28938b7d381cf744b9f7bde4ba23f6e1811ec038786db80c5edc5558220260615 globalCH aggregateSpend SubmittableReport 2025
Texto indexado de https://blob.almirall.com/files/2026-06/20260615_globalCH_aggregateSpend_SubmittableReport_2025.pdf
almirall://content/almirall-com/7b60a3ad188425afb9d8623cd8f52da206bbae1ec4faf87b3b9f7ee7fb2bb79b20260616 globalAT aggregateSpend SubmittableReport
Texto indexado de https://blob.almirall.com/files/2026-06/20260616_globalAT_aggregateSpend_SubmittableReport.pdf
almirall://content/almirall-com/f57a5f5b3afca818f590847ffa392b11e1b906f56a8bab279e151b57f4743bf820260619 CZ SubmittableReport
Texto indexado de https://blob.almirall.com/files/2026-06/20260619_CZ_SubmittableReport.pdf
almirall://content/almirall-com/ae9499ddb99620fbe5fd38576625a3f0db1527557f3a1978c871975be1f87f9e20260619 PL SubmittableReport
Texto indexado de https://blob.almirall.com/files/2026-06/20260619_PL_SubmittableReport.pdf
almirall://content/almirall-com/d4b13f215ab53543e2572c7ec2bc8e939de0ba08d556f518df3cbb3faf78b1e920260619 SK SubmittableReport
Texto indexado de https://blob.almirall.com/files/2026-06/20260619_SK_SubmittableReport.pdf
almirall://content/almirall-com/163aa015cb24e6abebbb8cd23c80f9c13fd092bd00f7b750e38ccd9e1c7629ee21 20240408 Almirall IARC 2023 ENG 0
Texto indexado de https://blob.almirall.com/files/2026-03/21-20240408-Almirall-IARC-2023_ENG_0.pdf
almirall://content/almirall-com/24d25c82aa0e3de56cffaea1a84023e990d59ee9f79ceb879fd5b60d5e59fcce21 20240408 Almirall IARC 2023 ENG 1
Texto indexado de https://blob.almirall.com/files/2026-03/21-20240408-Almirall-IARC-2023_ENG_1.pdf
almirall://content/almirall-com/c6b2c2fc5c71d51865a0726364729df783cb2cb5ddbf66e2ecb12f3627365dcf21 20240408 Almirall IARC 2023 ENG 2
Texto indexado de https://blob.almirall.com/files/2026-03/21-20240408-Almirall-IARC-2023_ENG_2.pdf
almirall://content/almirall-com/336112fb35e02421acfe35584e51176cbdbc6fe797d5babce9758fcd4b932a00210107 PR Almirall partners with Tyris ENG4711294
Texto indexado de https://blob.almirall.com/files/documents/210107_PR_Almirall%20partners%20with%20Tyris_ENG4711294.pdf
almirall://content/almirall-com/21731617ab7f37bef31c00a10e1c818685b2b2065544a59544182a1cdaa88485210209 ILU BJD 5YD final ENG4737327
Texto indexado de https://blob.almirall.com/files/documents/210209_ILU_BJD%205YD_final_ENG4737327.pdf
almirall://content/almirall-com/e4a31a34107aac8a19f8c6dad8b063cf4b36aaa15f1e0082f7f93672a29f8219210222 Dr Jorge Gallardo ENG DEF5083803
Texto indexado de https://blob.almirall.com/files/documents/210222%20Dr%20Jorge%20Gallardo_ENG_DEF5083803.pdf
almirall://content/almirall-com/c6bf78fe0448918ba18886a6e4e36e01455a0a15672db662a1f0c227af5c837e2105 EN Almirall celebrates 10 years in Italy169004
Texto indexado de https://blob.almirall.com/files/documents/2105_EN_Almirall_celebrates_10_years_in_Italy169004.pdf
almirall://content/almirall-com/a3e226bfe43fa83210ccaec1c74c47c7d6d0da8fab3081dddac66cd5ea4af5af210514 CHMP POpinion Klisyri ENG4831474
Texto indexado de https://blob.almirall.com/files/documents/210514_CHMP_POpinion_Klisyri_ENG4831474.pdf
almirall://content/almirall-com/e726dd34883736a8fbdab97e2cb8e453fab39c7f0e24af2b4af8abc8020f214f2106 EN Eklira Genuair by Almirall available in Spain for the treatment of COPD169023
Texto indexado de https://blob.almirall.com/files/documents/2106_EN_Eklira__Genuair__by_Almirall_available_in_Spain_for_the_treatment_of_COPD169023.pdf
almirall://content/almirall-com/16c83f06b98cad59253cacfa16b1e503a84e3f00fbde5f3f3fe8c77c37ffe082210701 Kaken Agreement4882069
Texto indexado de https://blob.almirall.com/files/documents/210701_Kaken_Agreement4882069.pdf
almirall://content/almirall-com/59b602a94003241220a0388992e19966e5c4b8c69c7e582cbfd6dd9497acad4d210705 PR Almirallshare Sixth Call4886975
Texto indexado de https://blob.almirall.com/files/documents/210705_PR_Almirallshare_Sixth_Call4886975.pdf
almirall://content/almirall-com/4a0984d9a2fc66b63f20c530785a70f1602ad83e96dd1db9f1588bf556131a10210706 Almirall MC2 EoP ENG4887553
Texto indexado de https://blob.almirall.com/files/documents/210706_Almirall_MC2_EoP_ENG4887553.pdf
almirall://content/almirall-com/937c676429bc2ab58213e9f660b2936adea8a10bff082a8e5dd46c5d477c0b2e210719 PR Approval Klisyri EC (1)4898974
Texto indexado de https://blob.almirall.com/files/documents/210719_PR_Approval_Klisyri%20EC%20(1)4898974.pdf
almirall://content/almirall-com/5d08c7da11befa56212731e98cc1a2e506a5d76498aceb495aecf87fed907d8d210726 PR H1 RESULTS 2021 ENG4904505
Texto indexado de https://blob.almirall.com/files/documents/210726_PR_H1%20RESULTS%202021_ENG4904505.pdf
almirall://content/almirall-com/3231590f99e3b95378d2265a8ed534d157e18f6d244abb5b59d77bcc1ee68de7210816 PR Lebrikizumab ADvocate 1 2 Mono Phase 3 ALM ENG4921636
Texto indexado de https://blob.almirall.com/files/documents/210816_PR%20Lebrikizumab%20ADvocate%201%202%20Mono%20Phase%203_ALM%20ENG4921636.pdf
almirall://content/almirall-com/78f3fecdef8f23ce793cc09e9a6606628c11edb083417f59226a2ee7e7051eb4210916 ALMIRALL PR pricing of the issuance of senior notes4947767
Texto indexado de https://blob.almirall.com/files/documents/210916_ALMIRALL_PR_pricing%20of%20the%20issuance%20of%20senior%20notes4947767.pdf
almirall://content/almirall-com/96e2d96af8bc14d7cd5b29b5d0198fdd5be8c9dd7e9f3735dcdf2db14e66cc79211028 PR WorldPsoriasisDay F4986291
Texto indexado de https://blob.almirall.com/files/documents/211028_PR_WorldPsoriasisDay_F4986291.pdf
almirall://content/almirall-com/368147f8800a97646d9f4e13f8545ac4c7a54f1d646d36400b889aa7f7d3e7da211115 PR 9M RESULTS 2021 ENG def5001290
Texto indexado de https://blob.almirall.com/files/documents/211115_PR_9M_RESULTS_2021_ENG_def5001290.pdf
almirall://content/almirall-com/4cbbcb0bffa5f9166b0a50f5d9a17c8648eea22d321a396475e9150cd2f0fbcb2114 EN Almirall commercialises Neurofarmagen an innovative genetic test169042
Texto indexado de https://blob.almirall.com/files/documents/2114_EN_Almirall_commercialises_Neurofarmagen__an_innovative_genetic_test169042.pdf
almirall://content/almirall-com/f0ab4d1647fc11ef94a17557e564e8de02be8f62fd8d461bb09225ed753f0f172117 EN Coordination among professionals is crucial for good vascular patient care169061
Texto indexado de https://blob.almirall.com/files/documents/2117_EN_Coordination_among_professionals_is_crucial_for_good_vascular_patient_care169061.pdf
almirall://content/almirall-com/940049940783e67346e67f90e7540f439b7bc84f244f3ea3ca2cf9c343679aa62156 EN Almirall presents the latest news in respiratory diseases169080
Texto indexado de https://blob.almirall.com/files/documents/2156_EN_Almirall_presents_the_latest_news_in_respiratory_diseases169080.pdf
almirall://content/almirall-com/78151050e5af586d99ed0f321bf6f2822874b258104bf59409c635597f678662220510 PR Almirall Inserm collab5159254
Texto indexado de https://blob.almirall.com/files/documents/220510_%20PR_Almirall_Inserm_collab5159254.pdf
almirall://content/almirall-com/5450a0ad83930cdfe184f2a0c0803b4d80d7bb0630de0f311905d99cb06dd744220519 PR Almirall Evotec Alliance5159614
Texto indexado de https://blob.almirall.com/files/documents/220519_%20PR_Almirall_Evotec_Alliance5159614.pdf
almirall://content/almirall-com/5ec27c7e6b3f1446fa48d34e198adc8e83a9164fc8a36142100ac298d5f8b930220525 PR AK Global Day5233604
Texto indexado de https://blob.almirall.com/files/documents/220525_PR_AK_Global_Day5233604.pdf
almirall://content/almirall-com/b7ceea44c7049a1b79bdf16e188a0a1d7da282e87dbee9631fffc36f7335b90a220525 PR Almirall Happify CLARO5233579
Texto indexado de https://blob.almirall.com/files/documents/220525_PR_Almirall_Happify_CLARO5233579.pdf
almirall://content/almirall-com/438efe5f72607617c6eb548dea007f57f2c4e61c17d553004a768f1eaa3afbc3220607 PR Lebrikizumab ADvocate 52 Week5178388
Texto indexado de https://blob.almirall.com/files/documents/220607_PR_Lebrikizumab_ADvocate_52%20Week5178388.pdf
almirall://content/almirall-com/9e575e679541a2647a3ded9bef3fc27abd96bb6e1f1ada629102dbe60de05876220613 PR Almirall Happify Launch CLARO5184457
Texto indexado de https://blob.almirall.com/files/documents/220613_PR_Almirall_Happify_Launch_CLARO5184457.pdf
almirall://content/almirall-com/392e981fd9deffc1206204b3798ba9debd4560e1c52a58bac385964e37c3af64220720 PR Almirall Call AlmirallShare5214646
Texto indexado de https://blob.almirall.com/files/documents/220720_%20PR_Almirall_Call_AlmirallShare5214646.pdf
almirall://content/almirall-com/2ba8b16add59b9968937640740bbd67c715bac4fad1442a44014f95518889ed8220725 PR H1RESULTS20225219528
Texto indexado de https://blob.almirall.com/files/documents/220725_PR_H1RESULTS20225219528.pdf
almirall://content/almirall-com/66214af79bc2c1658f47e0e6f121ed5bb4a249e8e7fa906e8fe064cb6efb21a3220901 PR EADV 2022 LebriCR EN 15253438
Texto indexado de https://blob.almirall.com/files/documents/220901_%20PR_EADV%202022_LebriCR-EN-15253438.pdf
almirall://content/almirall-com/b521f88d5d4e4b1bf20ffb2ee15ccf0e391fabf492df6ae2d71427fde5ebd8a6220908 PR Lebrikizumab ADv 52Week5258756
Texto indexado de https://blob.almirall.com/files/documents/220908_%20PR_Lebrikizumab_ADv_52Week5258756.pdf
almirall://content/almirall-com/7746f2b0a6005a816cb2c6e271361b28d190c951f71384c148a1ace2340e7635220922 PR Phase I ALM27134 Ichnos FINAL5269966
Texto indexado de https://blob.almirall.com/files/documents/220922_%20PR_Phase%20I_ALM27134_Ichnos_FINAL5269966.pdf
almirall://content/almirall-com/d7a8932922d29c0fd9378035a009e6f5e0d3211ae530e72b382066f1b3283f86220929 PR Almirall Simcere agreement5275357
Texto indexado de https://blob.almirall.com/files/documents/220929_%20PR_Almirall_Simcere_agreement5275357.pdf
almirall://content/almirall-com/5fcf120d2143f62dfe5faeef0191bd4bc9b827bad396ff5972ce3801ea3bde45221014 PR Almirall IQS agreement5289659
Texto indexado de https://blob.almirall.com/files/documents/221014_%20PR_Almirall_IQS_agreement5289659.pdf
almirall://content/almirall-com/3bf9f9c7c3cc3f2498495df7fec8778d85a45ed56c8ac18c8c59cd73d3715020221018 PR Almirall Czech Republic subsidiary5311027
Texto indexado de https://blob.almirall.com/files/documents/221018_%20PR_Almirall_Czech_Republic_subsidiary5311027.pdf
almirall://content/almirall-com/c40aa1c3c5e6ff9a412ffb2f482067b87856be5b4edacae94fc434f0e8683725221028 PR Lebrikizumab Filing EMA5301856
Texto indexado de https://blob.almirall.com/files/documents/221028_%20PR_Lebrikizumab_Filing_EMA5301856.pdf
almirall://content/almirall-com/c338a527f2d896ccaaf1edf6d2acfefd9f2609dd476cfd98a48e7abf3fec8015221110 PR 9MRESULTS2022 ALMIRALL5312756
Texto indexado de https://blob.almirall.com/files/documents/221110_PR_9MRESULTS2022_%20ALMIRALL5312756.pdf
almirall://content/almirall-com/dfb9690440ef401bc1464dbe636efa856c6f1890c56bee52f1ff75ea19545419221128 PR Almirall Facilitate 5327464
Texto indexado de https://blob.almirall.com/files/documents/221128_%20PR_Almirall_Facilitate_5327464.pdf
almirall://content/almirall-com/76b0857df03eace2d6718c6ba534023218d7320225f4c13f03efee458bb1f42e221130 PR Mercedes Diz MB5329213
Texto indexado de https://blob.almirall.com/files/documents/221130_%20PR_Mercedes_Diz_MB5329213.pdf
almirall://content/almirall-com/c1b9049d749697dd26e59c93040233edae51a104635ed3d7d8530156c1917895230104 PR Almirall JPMorgan 5357283
Texto indexado de https://blob.almirall.com/files/documents/230104_%20PR_Almirall_JPMorgan_5357283.pdf
almirall://content/almirall-com/0589ec2ffe8d9293195ed65c0c49de4042c97f46a0642afeafabb76d166220aa230220 PR Almirall FYFR 2022 5395903
Texto indexado de https://blob.almirall.com/files/documents/230220_PR_Almirall_FYFR%202022_5395903.pdf
almirall://content/almirall-com/38a899ca98dd5be2bb5742a41bb3d2db89f21a7760cd7bb24ac447e3874e04b2230227 PR Almirall ZeClinics ENG5401643
Texto indexado de https://blob.almirall.com/files/documents/230227_%20PR_Almirall_ZeClinics_ENG5401643.pdf
almirall://content/almirall-com/e21bc53f29c7d881f6976e40d8e3f5db3aa4c2a791a4b689f7347e79a9748166230331 PR ALM Lebrikizumab publication NEJM FINAL update 4abril5429575
Texto indexado de https://blob.almirall.com/files/documents/230331_%20PR_ALM%20Lebrikizumab%20publication%20NEJM_FINAL_update%204abril5429575.pdf
almirall://content/almirall-com/65bbc9ad60457febc91719905ec66b1ddb82a108387a8811b0dde3095582b702230412 PR Almirall POSITIVE study BJM 5440181
Texto indexado de https://blob.almirall.com/files/documents/230412_%20PR_Almirall_POSITIVE_study_BJM_5440181.pdf
almirall://content/almirall-com/09dc0da1b8a675e94b53da80bae84b3defa7aad5d9790b70442d9419156980de230501 PR Almirall RAD5459075
Texto indexado de https://blob.almirall.com/files/documents/230501_%20PR_Almirall__RAD5459075.pdf
almirall://content/almirall-com/2086b823d68a606b7c0e64ad3d3f74bb2493fe29d9d93ed20e4ed2e89cb918e1230508 PR Almirall Q1 FR ENG5464141
Texto indexado de https://blob.almirall.com/files/documents/230508__PR_Almirall%20Q1%20FR_ENG5464141.pdf
almirall://content/almirall-com/976761cb4a995fe5ea47969b5a1129ba3c23e4dfdb507e556ec8bf989caac33a230523 NP Almirall AK Global Day GLOBAL5478565
Texto indexado de https://blob.almirall.com/files/documents/230523_NP_Almirall_AK%20Global%20Day_GLOBAL5478565.pdf
almirall://content/almirall-com/aa80dcbc6989047cf32255664d76d55166caa46ef3e57c528b02dd80373a8d5d230525 PR Almirall CRG EN5479493
Texto indexado de https://blob.almirall.com/files/documents/230525_%20PR_Almirall_CRG_EN5479493.pdf
almirall://content/almirall-com/08df138d5c6e4f15ab347465d1cb57dfaf67e6bf32528e8928caaf0592f86c81230619 PR Almirall series Nina5679515
Texto indexado de https://blob.almirall.com/files/documents/230619_%20PR_Almirall_series_Nina5679515.pdf
almirall://content/almirall-com/a0332f3c09a88778926b337b00c507b2bd0d22a5caf13777af2bf39c89a9335f230707 PR Almirall POSITIVE first results5516386
Texto indexado de https://blob.almirall.com/files/documents/230707_%20PR_Almirall_POSITIVE_first_results5516386.pdf
almirall://content/almirall-com/0648f37c3d81eb3ba35b5d6723ccb7a79cf43244018171a26d709821b5f9a4db230720 Almirall SBTI NetZero5527601
Texto indexado de https://blob.almirall.com/files/documents/230720_Almirall_SBTI_NetZero5527601.pdf
almirall://content/almirall-com/318239f6dce3ef4ed0b822e39fdcac20e25553ea6815bfd9f76d6ff81b0badf7230724 PR Almirall H1 FR5530820
Texto indexado de https://blob.almirall.com/files/documents/230724_PR_Almirall%20H1%20FR5530820.pdf
almirall://content/almirall-com/f0e794e789ed1871c0f2d069cab5b1346d97a3bf1f6065fceacf6b7b7784b6152308 EN 2012 results in line with guidance positioning Almirall for transformative growth from 2013169099
Texto indexado de https://blob.almirall.com/files/documents/2308_EN_2012_results_in_line_with_guidance__positioning_Almirall_for_transformative_growth_from_2013169099.pdf
almirall://content/almirall-com/502571b86763bd177fbcda472ccc349728cef9649240e29ea1d32d486d88c95a2309 EN Almirall s financial calendar 2013169118
Texto indexado de https://blob.almirall.com/files/documents/2309_EN_Almirall_s_financial_calendar_2013169118.pdf
almirall://content/almirall-com/0249c8dd01d6d95da25471f55c7fbcf6d64ade27bb3e3548b9700007d85a5e09230914 PR Almirall World Atopic Dermatitis Day5574864
Texto indexado de https://blob.almirall.com/files/documents/230914_PR_Almirall_World%20Atopic%20Dermatitis%20Day5574864.pdf
almirall://content/almirall-com/7379f7532d3201ead45e252980f16fa34ab4a45fff76d96c63c8f01f8b12bb3b230915 PR Almirall CHMP Lebrikizumab5576025
Texto indexado de https://blob.almirall.com/files/documents/230915_%20PR_Almirall_CHMP_Lebrikizumab5576025.pdf
almirall://content/almirall-com/d2b3893a60e9d376d63ecbcd07158cfd4f2f24ecf218c5893f6e3f66ea9c6e06231010 PR Almirall Centrient5595826
Texto indexado de https://blob.almirall.com/files/documents/231010_%20PR_Almirall_Centrient5595826.pdf
almirall://content/almirall-com/509a0adba5e546533d8f0f23d375fb8754b80ea07afc7efedbc5bd1e7868f67d231011 PR Almirall EADV Tildrakizumab5596731
Texto indexado de https://blob.almirall.com/files/documents/231011_PR_Almirall_EADV_Tildrakizumab5596731.pdf
almirall://content/almirall-com/dc270d1271964c671f07b0b88055fee8f3b4ceae3c41f98a060d8ab43121feec231013 PR Almirall EADV Lebrikizumab5598471
Texto indexado de https://blob.almirall.com/files/documents/231013_PR_Almirall_EADV_Lebrikizumab5598471.pdf
almirall://content/almirall-com/58313810709877f426ff352952a71786086ea59a7e95785f000f180ff458a4e2231020 PR Almirall Fall Clinical Lebrikizumab5604306
Texto indexado de https://blob.almirall.com/files/documents/231020_PR_Almirall_Fall_Clinical_Lebrikizumab5604306.pdf
almirall://content/almirall-com/8b6823ed663065b6aed1e619509d4187874d41ac48f435972d57cb8e77617cd5231024 PR Almirall new call Almirallshare5607483
Texto indexado de https://blob.almirall.com/files/documents/231024_PR_Almirall_new_call_Almirallshare5607483.pdf
almirall://content/almirall-com/2f131cfd1b29c6e93f3209a05b78357ba1c837b381fa581c9b3c83d78a960d40231027 PR Almirall World Psoriasis Day 5610325
Texto indexado de https://blob.almirall.com/files/documents/231027_PR_Almirall_World%20Psoriasis%20Day_5610325.pdf
almirall://content/almirall-com/be7ff8ffd9c41632e4a490c89f8cc5a0fa14eb739b9f85ebc00b71c516b207c2231109 PR Almirall FinancialResults 9M ENG5620656
Texto indexado de https://blob.almirall.com/files/documents/231109_PR_Almirall_FinancialResults_9M%20ENG5620656.pdf
almirall://content/almirall-com/54978a75475f21dd0410e4b587dbf668a0e0850c0e1201c96805e0796a01ec84231114 PR Almirall Absci partnership5624985
Texto indexado de https://blob.almirall.com/files/documents/231114_%20PR_Almirall_Absci_partnership5624985.pdf
almirall://content/almirall-com/836798eb077b554340219f5403f3c04b2342a12edd35de5016b3696da8764b74231117 PR Almirall Ebglyss EC Approval5628254
Texto indexado de https://blob.almirall.com/files/documents/231117_%20PR_Almirall_Ebglyss_EC_Approval5628254.pdf
almirall://content/almirall-com/d3e881f2a381e792ca3ce1e9ebbc3347dece64354f559533033c0da16e7a5552231205 PR Almirall BSC NostrumBioDiscovery ENG5644953
Texto indexado de https://blob.almirall.com/files/documents/231205_%20PR_Almirall_BSC_NostrumBioDiscovery_ENG5644953.pdf
almirall://content/almirall-com/3a03ba03d6446a551b5e91ff9b678092d0121187753be099afe22366c2351ab3231212 PR Almirall eTheRNA 5650572
Texto indexado de https://blob.almirall.com/files/documents/231212_%20PR_Almirall_eTheRNA_5650572.pdf
almirall://content/almirall-com/9b5170764d50fb03416941a151dd0b2bdfbbdc5d2184c5abc6e574b49c148718231221 PR Almirall ALM223 Phase I Study5658424
Texto indexado de https://blob.almirall.com/files/documents/231221_%20PR_Almirall_ALM223_Phase%20I%20Study5658424.pdf
almirall://content/almirall-com/c9f19c2392d2b0801fd4d1d39d60d8694d3d630eb09e4e90761e2dbd1f73d2032321 EN PR Almirall opens a new affiliate in Canada169137
Texto indexado de https://blob.almirall.com/files/documents/2321_EN_PR_Almirall_opens_a_new_affiliate_in_Canada169137.pdf
almirall://content/almirall-com/0d173eda3b4f4011cc048698c8c53a477614a74c92e265143b87236f803a087a2379 EN PR Spain regulatory approval final with MRP169175
Texto indexado de https://blob.almirall.com/files/documents/2379_EN_PR_Spain_regulatory_approval_final_-with_MRP169175.pdf
almirall://content/almirall-com/10bc4ab41e181a6ab653d8a1d56e20c483f2230e4bded614d153feb66e45a81524 02 25 PR Almirall FinancialResults FY24.docx5708204
Texto indexado de https://blob.almirall.com/files/documents/24-02-25_PR_Almirall_FinancialResults_FY24.docx5708204.pdf
almirall://content/almirall-com/0230a172b16d581c77f03899caa0a8f5079e644bece050735a6f7496d82e8734240119 PR Almirall JP Morgan Healthcare Conference5656578
Texto indexado de https://blob.almirall.com/files/documents/240119_%20PR_Almirall_JP%20Morgan%20Healthcare%20Conference5656578.pdf
almirall://content/almirall-com/e1dbf215921d5258fa1370ce2f789a69542109a47df683825a3a2626c6ec8315240131 PR Almirall collaboration with Microsoft5692539
Texto indexado de https://blob.almirall.com/files/documents/240131_%20PR_Almirall%20collaboration%20with%20Microsoft5692539.pdf
almirall://content/almirall-com/c8ec8319a9c6656171d352d3435a4a7ef18d29c51ece5fbb608306553ecc7db6240208 PR Almirall CRG collaboration5699344
Texto indexado de https://blob.almirall.com/files/documents/240208_PR_Almirall_CRG_collaboration5699344.pdf
almirall://content/almirall-com/0fab459b7bd8d460ae8d889b0cd701fed1dd304ae4cecc4ef13e6dd365ce9d80240212 PR Almiral CDP Climate Change Score5702844
Texto indexado de https://blob.almirall.com/files/documents/240212_%20PR_Almiral_CDP_Climate%20Change%20Score5702844.pdf
almirall://content/almirall-com/1a63c021686207a9e0f0ce1f397c5b2513dca5a30c3cbc6c94b7d418755375fe240219 PR Almirall Agreement NovoNordisk5708438
Texto indexado de https://blob.almirall.com/files/documents/240219_PR_Almirall_Agreement_NovoNordisk5708438.pdf
almirall://content/almirall-com/49f79b8ebb24735b9c3a70d55766233c3085d6a2c65298b43471f949239044de240513 Q1FR24 Almirall ENG5779868
Texto indexado de https://blob.almirall.com/files/documents/240513_Q1FR24_Almirall_ENG5779868.pdf
almirall://content/almirall-com/c116c14ded124b88e41ddf05032ec89e3c16752c067c9af68c95ceda309dbc27240524 PR AKGlobalDay5792784
Texto indexado de https://blob.almirall.com/files/documents/240524_PR_AKGlobalDay5792784.pdf
almirall://content/almirall-com/b30133a8d36211eba8775aff9850b788b16a015b425017ed3ee15335e8e7e61d240528 EBG Launch Norway ENG5798796
Texto indexado de https://blob.almirall.com/files/documents/240528_EBG_Launch%20Norway_ENG5798796.pdf
almirall://content/almirall-com/b838cb4640cc3644e0e6190bfa558510d8c2c61d8498e8340dfe1abc5f8d4800240627 PR Almirall POSITIVE W52 ENG5823498
Texto indexado de https://blob.almirall.com/files/documents/240627_PR_Almirall_POSITIVE%20W52_ENG5823498.pdf
almirall://content/almirall-com/d503e7ef79299087263cf2601314b5e50c1567046555f01e5482ebd35e782506240702 PR Almirall Act4Impact launch final5825581
Texto indexado de https://blob.almirall.com/files/documents/240702_PR_Almirall_Act4Impact%20launch_final5825581.pdf
almirall://content/almirall-com/d3eac4a092af0d5e858c0d5ee623e4e308dd1b99549d2fb88b67624f831f46ad240923 PR Almirall EADV Congress PRE final5896490
Texto indexado de https://blob.almirall.com/files/documents/240923_PR_Almirall_EADV%20Congress%20PRE_final5896490.pdf
almirall://content/almirall-com/701b2c5f07afac856fbe50be3bf95898fcf0e391a22aa5c543e30f963bb96305240925 PR Almirall EADV Congress Lebrikizumab5899013
Texto indexado de https://blob.almirall.com/files/documents/240925_PR_Almirall_EADV%20Congress_Lebrikizumab5899013.pdf
almirall://content/almirall-com/19d5b68b78557277dd515ee870ee3feac8112f4e8076b9c94cd72ffa86c72419241015 Almirall KAKEN EoP ENG FINAL5914199
Texto indexado de https://blob.almirall.com/files/documents/241015_Almirall_KAKEN_EoP_ENG_FINAL5914199.pdf
almirall://content/almirall-com/1ea38f330cfdeb915df6d4a8087de55de2930f37df8c568827e0f6cfd334a41d241028 PR Almirall Immunoskin Meeting ENG5926688
Texto indexado de https://blob.almirall.com/files/documents/241028_PR_Almirall_Immunoskin%20Meeting_ENG5926688.pdf
almirall://content/almirall-com/5c9511c59e361d3b928388a2d58f562c0ed466c6f79bf948a34fea1ccb0dc8bc241028 PR Almirall World Psoriasis Day v15927513
Texto indexado de https://blob.almirall.com/files/documents/241028_PR_Almirall_World%20Psoriasis%20Day_v15927513.pdf
almirall://content/almirall-com/242071add9abbb73e42369984de0b91f9e7b2a601cf048b65e94f60d714b0112241204 PR 80 Anniversary Institutional Event ENG ap withquote5957632
Texto indexado de https://blob.almirall.com/files/documents/241204_PR_80%20Anniversary%20Institutional%20Event%20ENG_ap_withquote5957632.pdf
almirall://content/almirall-com/ab9b8619275d61dfe7222c0edfc17d6f1d80612b8a34a43d3d81835462b12b0b2428 EN Closing Hermal169232
Texto indexado de https://blob.almirall.com/files/documents/2428_EN_Closing_Hermal169232.pdf
almirall://content/almirall-com/31c26c57015001edd6dff1045929fe01803f33efedc23af9fe5b99d7e244fb022429 EN H1 2007 Results169251
Texto indexado de https://blob.almirall.com/files/documents/2429_EN_H1_2007_Results169251.pdf
almirall://content/almirall-com/338fb023197f4a1e5169343afbb56ff75a00817958b691429b3ae8dbd74860672500 EN PR LAC30 results English final169270
Texto indexado de https://blob.almirall.com/files/documents/2500_EN_PR_LAC30_results_English_final169270.pdf
almirall://content/almirall-com/5fc7c884a6a17580e5a5f17a4ff1766d38e0bf6f8d589bcb5390d759b5ab7ec92504 EN AUGMENT results LAC31 English169289
Texto indexado de https://blob.almirall.com/files/documents/2504_EN_AUGMENT_results_-_LAC31-_English169289.pdf
almirall://content/almirall-com/8b6f71188a835785680da2ff19bd797e437044f54bcbfbe7a67b67c4a49dce50250430 Press Release Hats On Challenge EU APROBADO (1)6087983
Texto indexado de https://blob.almirall.com/files/documents/250430_Press%20Release_Hats%20On%20Challenge_EU_APROBADO%20(1)6087983.pdf
almirall://content/almirall-com/5b245f62f9fd60eab6175fba9b3e04a7efbabc50b51e715678155847cb4dd79a2506 EN Almirall maintains its shareholder return May313169308
Texto indexado de https://blob.almirall.com/files/documents/2506_EN_Almirall_maintains_its_shareholder_return_May313169308.pdf
almirall://content/almirall-com/033386e3ed9c914b37c1e2093534a69779b601ae5a065a3ed9222c66587cf51525062019 FINAL Dermira Almirall ENG4146830
Texto indexado de https://blob.almirall.com/files/documents/25062019_FINAL_Dermira-Almirall_ENG4146830.pdf
almirall://content/almirall-com/dead972fcdfd6ee975d4f081e0dc249be62fbec97c615bd8a5d0b4f136637ca52509 EN PR Almirall begins the transformation169327
Texto indexado de https://blob.almirall.com/files/documents/2509_EN_PR_Almirall_begins_the_transformation169327.pdf
almirall://content/almirall-com/b1671948b6215654101ee9216474e112925ce89296f14be29113669c30ec1c4d2514 EN Final World MS Day press release169346
Texto indexado de https://blob.almirall.com/files/documents/2514_EN_Final_World_MS_Day_press_release169346.pdf
almirall://content/almirall-com/5aa89c2aebd2a2e61b727c16b396b3090a7c8e9e0e4a645d3a6cc13cef5f7be32518 EN Almirall launches Constella169365
Texto indexado de https://blob.almirall.com/files/documents/2518_EN_Almirall_launches_Constella169365.pdf
almirall://content/almirall-com/b796d9ee0e931bd0eca4823a4872106790683c8d035302f36432e360bdf1e4272522 EN 2013 0618 PR Energy management system 13169384
Texto indexado de https://blob.almirall.com/files/documents/2522_EN_2013_0618_PR_Energy_management_system_13169384.pdf
almirall://content/almirall-com/7c0b39c781a3cf9c7c7dd5830dd334f6e378e334caac1f5aa268fbdeb64689ea2527 EN 2013 07 17 PR Occupational health and safety 13169422
Texto indexado de https://blob.almirall.com/files/documents/2527_EN_2013_07_17_PR_Occupational_health_and_safety_13169422.pdf
almirall://content/almirall-com/3947b2feea6836800b3f88ced50784213babf68c63ead281f0dccfa3a5d3e4752532 EN 2013 07 29 PR Almirall financial results H1 English169441
Texto indexado de https://blob.almirall.com/files/documents/2532_EN_2013_07_29_PR_Almirall_financial_results_H1_English169441.pdf
almirall://content/almirall-com/b1c37ef0d06860c68eb8fc10ff996b0eee64d97d38d21aa4e939a559a9432eea2539 EN 2013 09 05 PR Opening Canada169460
Texto indexado de https://blob.almirall.com/files/documents/2539_EN_2013_09_05_PR-Opening_Canada169460.pdf
almirall://content/almirall-com/bc04b632a58b26d59fd9aac58f36456e3559fc0997e1fa21be548364ddb4ee492542 EN 13 09 05 Press release ERS169479
Texto indexado de https://blob.almirall.com/files/documents/2542_EN_13_09_05_Press_release-_ERS169479.pdf
almirall://content/almirall-com/f1328263aec5176da7d0b3794400c92d3234b4ebf9808f63425db2dee6a6d5962544 EN 2013 09 25 PR ECTRIMS English169498
Texto indexado de https://blob.almirall.com/files/documents/2544_EN_2013_09_25_PR_ECTRIMS_English169498.pdf
almirall://content/almirall-com/38d47a5c53f885f125708918d711457002549101abceb70ebc1733daed1674a02589 EN 2013 08 27 NP FundacionCotecEspecializados.docx English169517
Texto indexado de https://blob.almirall.com/files/documents/2589_EN_2013_08_27_NP-FundacionCotecEspecializados.docx_English169517.pdf
almirall://content/almirall-com/b2476822b6c000137167f2069515b630b1adc1469da9bc8e969f79bada2d91812593 EN 2013 11 04 Combo aclidinium EU Filing Press Release169536
Texto indexado de https://blob.almirall.com/files/documents/2593_EN_2013_11_04_Combo_aclidinium_EU_Filing_Press_Release169536.pdf
almirall://content/almirall-com/4dc0e93c1be33e5ece99a685823b27e3f6a9f3610320cea4f75c904f38665af32595 EN 2013 11 11 PR Almirall financial results Q3 English169555
Texto indexado de https://blob.almirall.com/files/documents/2595_EN_2013_11_11_PR_Almirall_financial_results_Q3_English169555.pdf
almirall://content/almirall-com/7f81d6d7858040ad24a3cb5a79930d8750a3df769233c7a0d444dc96393d225f2597 EN 2013 11 18 COPD Day Press release169574
Texto indexado de https://blob.almirall.com/files/documents/2597_EN_2013_11_18_COPD_Day_Press_release169574.pdf
almirall://content/almirall-com/b1668b06e1484e3ac29d02fc3afeba8203532dae27b638876e737d29e2aae9c32600 EN 2013 12 05 Almirall announces a reorganization program affecting the group in Europe169593
Texto indexado de https://blob.almirall.com/files/documents/2600_EN_2013_12_05-Almirall_announces_a_reorganization_program_affecting_the_group_in_Europe169593.pdf
almirall://content/almirall-com/3d2b9c1c4b136de1c03a22de3319fc28bd8b03de3cfbb64f035f2d07ac6a0474260322 PR Lebrikizumab ADvocate AAD 2022 (1)5111248
Texto indexado de https://blob.almirall.com/files/documents/260322_PR_Lebrikizumab_ADvocate_AAD_2022_%20(1)5111248.pdf
almirall://content/almirall-com/266ef50c08ed331d243d2ae1c4a6a2b2918c14b0311b68565a58d8c945517046290722 PR AlmirallShare Call5 ENG final4528606
Texto indexado de https://blob.almirall.com/files/documents/290722_PR_AlmirallShare_Call5_ENG_final4528606.pdf
almirall://content/almirall-com/29d88ebe3674fe33b5e1d81fa6af431307b8327ccd3f1774c11ed147ffd732c233RD CONGRESS OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/33rd-congress-european-academy-dermatology-and-venereology-eadv
almirall://content/almirall-com/8f70c48de0f1d4e432dc9ac5fb45ba1a056367e313b8bac0763b3544498244293rd Quarter Results | Almirall
Texto indexado de https://almirall.com/news-media/newsroom/3rd-quarter-results
almirall://content/almirall-com/d37bb172bd2e26413ca0cbdce5ed3d03695153530f42687e7eb9e9feac84618b4. Almirall Shareholders Agreement (ENG)
Texto indexado de https://blob.almirall.com/files/2026-01/4.%20Almirall%20-%20Shareholders_Agreement%20(ENG).pdf
almirall://content/almirall-com/f7e46b3d3dbc5793af2775f03fc2ba542e0b374b86c13fbf38fee93fa71eb82f5 Net Zero Infographic updated
Texto indexado de https://blob.almirall.com/files/2026-05/5-Net-Zero-Infographic-updated.pdf
almirall://content/almirall-com/e5313ee062ad130aa0f12000131fe5692b1cafb367c51313b311bb2e771fba2e651 EN NP Convenio F Galatea English165152
Texto indexado de https://blob.almirall.com/files/documents/651_EN_NP%20Convenio%20F%20Galatea%20English165152.pdf
almirall://content/almirall-com/9e3c98cb0c91a4e3a840a15cd64d61aee03b888930741e05ff80480d7e93feac655 EN 07 OHSAS certificate (ingles)165171
Texto indexado de https://blob.almirall.com/files/documents/655_EN_07%20OHSAS%20certificate%20(ingles)165171.pdf
almirall://content/almirall-com/db981feee345c8bbae3d9d186424a68b7878d8bf9974494af0ef8f6847bff782656 EN Almirall premio mejor compania (ingles)165185
Texto indexado de https://blob.almirall.com/files/documents/656_EN_Almirall%20premio%20mejor%20compania%20(ingles)165185.pdf
almirall://content/almirall-com/c86a3785e33653cf31529498228f61a71b9962f5add718f85535f233be29ea4c661 EN PR First day of listing165213
Texto indexado de https://blob.almirall.com/files/documents/661_EN_PR%20First%20day%20of%20listing165213.pdf
almirall://content/almirall-com/70ee3ab4e12a7297e5da200810f27e70ca7959cdc23fb08bf244b27329190365662 EN Appointment Jordi Molina165232
Texto indexado de https://blob.almirall.com/files/documents/662_EN_Appointment%20Jordi%20Molina165232.pdf
almirall://content/almirall-com/342bd1c5f94f1ed8475f93d9c3955e21e48de45a6bd0308ca356f57ec6f5d95b663 EN PR prospectus results 2006165251
Texto indexado de https://blob.almirall.com/files/documents/663_EN_PR%20prospectus%20results%202006165251.pdf
almirall://content/almirall-com/b5dcb616d5b32578524cdde905da4b0f85c064790f4218bb257e5d3fb5998d9f664 EN NP Tramo empleados (ingles)165270
Texto indexado de https://blob.almirall.com/files/documents/664_EN_NP%20Tramo%20empleados%20(ingles)165270.pdf
almirall://content/almirall-com/ef803bce9ce4414bfa3e941bdf9f4f1b43de55d5faba3146644effcfa8ef7920665 EN Short text for global (ingles)165289
Texto indexado de https://blob.almirall.com/files/documents/665_EN_Short%20text%20for%20global%20(ingles)165289.pdf
almirall://content/almirall-com/02a80a178094a0be03a32067e4be34776bddc8c521d6636263d4549b953137b7666 EN Nota de prensa (ingles)165308
Texto indexado de https://blob.almirall.com/files/documents/666_EN_Nota%20de%20prensa%20(ingles)165308.pdf
almirall://content/almirall-com/6a789f60a1c08df2ce7e5923919ee3028339f1f1fa2669897aebf4bdc4595ada667 EN PR Positive first day of trading165327
Texto indexado de https://blob.almirall.com/files/documents/667_EN_PR%20Positive%20first%20day%20of%20trading165327.pdf
almirall://content/almirall-com/1e2c4a1a3fe9f2221e5d12dcb7033ff1915189fbeb05c5070e55cb7849fe9021668 EN Press release Hermal acquisition165346
Texto indexado de https://blob.almirall.com/files/documents/668_EN_Press%20release%20Hermal%20acquisition165346.pdf
almirall://content/almirall-com/756dbc061045bf0648fc77408c17f75a6e35fef33f965c71a4e50d2d3cdade2d670 EN PR Global Medical Director Almirall RD (ingles)165374
Texto indexado de https://blob.almirall.com/files/documents/670_EN_PR%20Global%20Medical%20Director%20Almirall%20RD%20(ingles)165374.pdf
almirall://content/almirall-com/4910089e02d66c0f26e45e747ced2aa377d3686e7d881f6957866db53f1707e3671 EN Resultados 1er simestre 2007 (ingles)165388
Texto indexado de https://blob.almirall.com/files/documents/671_EN_Resultados%201er%20simestre%202007%20(ingles)165388.pdf
almirall://content/almirall-com/1b63faf546bfc3887aaddc45f02878f7257ac5d9a0797d20173923ea47114a00673 EN Press release (English)165407
Texto indexado de https://blob.almirall.com/files/documents/673_EN_Press%20release%20(English)165407.pdf
almirall://content/almirall-com/d2f1eaa6732354bcb0df66b7a8ff4eeb65433221008d5376262831f702fd9a28674 EN Press Release165426
Texto indexado de https://blob.almirall.com/files/documents/674_EN_Press%20Release165426.pdf
almirall://content/almirall-com/f7ad46ef350ff2a1b0436d7c10a635032d9eb37fa1b2c20d89999ef4caebec98675 EN Press release165445
Texto indexado de https://blob.almirall.com/files/documents/675_EN_Press%20release165445.pdf
almirall://content/almirall-com/d13f15697d06efc04c3a30fefb7d883fd9631cceb0d5029a8607291848d398c1676 EN PR Appointment Klaus Melchers165464
Texto indexado de https://blob.almirall.com/files/documents/676_EN_PR%20Appointment%20Klaus%20Melchers165464.pdf
almirall://content/almirall-com/e458e95b0d6ddfe68ae09fa1909d865c2b20c6968a059c0a873dea0b6fe5e357678 EN Nota de prensa (ingles)165483
Texto indexado de https://blob.almirall.com/files/documents/678_EN_Nota%20de%20prensa%20(ingles)165483.pdf
almirall://content/almirall-com/eed7617b5d9266de89f867ca4804498ff8307ac7464f9adfff6c69737ce55a6f679 EN PR Appointment165502
Texto indexado de https://blob.almirall.com/files/documents/679_EN_PR%20Appointment165502.pdf
almirall://content/almirall-com/d8294480b1db24dd9dcd3b7cc6074ccd4e827ee6896019953af48189b3feffa9680 EN PR Appointments165521
Texto indexado de https://blob.almirall.com/files/documents/680_EN_PR%20Appointments165521.pdf
almirall://content/almirall-com/afb0288ee04e63f69a4e84e9d151dcded2542c2d4781890a2adc77b02b3e1dc5681 EN Nota de prensa ingles165540
Texto indexado de https://blob.almirall.com/files/documents/681_EN_Nota%20de%20prensa%20-%20ingles165540.pdf
almirall://content/almirall-com/599ca8afc2ff9b90d62511adaace3fa437ae8d4f595fa577219080a2cefab800682 EN Press release165559
Texto indexado de https://blob.almirall.com/files/documents/682_EN_Press%20release165559.pdf
almirall://content/almirall-com/28fc476e54cc134d378c29f55bda2853c9655dff519f7da32cc6605443aaedfe683 EN Press release165578
Texto indexado de https://blob.almirall.com/files/documents/683_EN_Press%20release165578.pdf
almirall://content/almirall-com/b045b7870e584d07d98e2eaab0c855b62a9f189a7ad92100ccb1178c2008c547684 EN Press release165597
Texto indexado de https://blob.almirall.com/files/documents/684_EN_Press%20release165597.pdf
almirall://content/almirall-com/1d7e71ff32cb6c18509254cb1fbab56b56ee45bc53b1eeb0d860314a735ed456689 EN PR Appointment (English)165616
Texto indexado de https://blob.almirall.com/files/documents/689_EN_PR%20Appointment%20(English)165616.pdf
almirall://content/almirall-com/a0e256e5169eef619d6121f62fea55045f3c3634ec342545b6761a62cf7eece7690 EN Press Release165635
Texto indexado de https://blob.almirall.com/files/documents/690_EN_Press%20Release165635.pdf
almirall://content/almirall-com/58dab537538da351d25feb122befef307196469594e73f2e02c1768bbb1c467b691 EN Press Release165654
Texto indexado de https://blob.almirall.com/files/documents/691_EN_Press%20Release165654.pdf
almirall://content/almirall-com/68bc3c38e226fa84a43e2c60f3c57f1f5ea4d08e6fa7f0e2322856d0392c698b692 EN PR165673
Texto indexado de https://blob.almirall.com/files/documents/692_EN_PR165673.pdf
almirall://content/almirall-com/e9b339b1a4bda4360099ada351f263f6157fbdce53814d2051d7d3f432b8e99e693 EN PR165692
Texto indexado de https://blob.almirall.com/files/documents/693_EN_PR165692.pdf
almirall://content/almirall-com/adb2166c4285a8f6cace1e5134c0e90ba003a9beb18773c09ceb07d4928dad35694 EN PR165711
Texto indexado de https://blob.almirall.com/files/documents/694_EN_PR165711.pdf
almirall://content/almirall-com/9d62fc3c955941bc932098818890a5bbb31243291e228ba45b3909b704f91d64695 EN PR165730
Texto indexado de https://blob.almirall.com/files/documents/695_EN_PR165730.pdf
almirall://content/almirall-com/6df81857dd12643752d9c82b2fbbe320d3d7014a9cd8574739bf8eea198fa611696 EN PR165749
Texto indexado de https://blob.almirall.com/files/documents/696_EN_PR165749.pdf
almirall://content/almirall-com/4b566f924fef1c004f49cdfb10c2a284a37eb9e0e237bdeec1cb7cbfb1250a45697 EN PR165768
Texto indexado de https://blob.almirall.com/files/documents/697_EN_PR165768.pdf
almirall://content/almirall-com/839e994156b03ff4058bdb2c57c4e9a0b031c27a345487d4430246caf4a35365698 EN PR165787
Texto indexado de https://blob.almirall.com/files/documents/698_EN_PR165787.pdf
almirall://content/almirall-com/4763e6c6d07373d3076fd511dd0ca54666d6dee55343066797809e82cf86f7b790-day uptime
A lightweight connection check about every six hours, sampled on hosts with many listings. It shows the server answered, not that its tools work.
- 2026-11-07: 1 of 1 checks answered
30-day availability
Aggregated from read-only remote checks; this is not a tool-execution or security guarantee.
- Successful checks
- 1 of 1 (100%)
- Average latency
- 15369 ms
- 95th percentile latency
- 15369 ms
Maintenance history
Public check and source-refresh events. Editorial and ownership records remain private.
- · probe · passed · 15369 ms · metadata changed · 14 tool(s), 500 resource(s) (partial: item-cap); warnings: Advertises resources/templates/list but does not implement it
Connect from your client
Each snippet registers the same endpoint; pick the client you use.
Claude Code
claude mcp add --transport http almirall-mcp https://mcp.almirall.com/mcpCodex
codex mcp add almirall-mcp --url https://mcp.almirall.com/mcpCursor
{
"mcpServers": {
"almirall-mcp": {
"url": "https://mcp.almirall.com/mcp"
}
}
}Cline
{
"mcpServers": {
"almirall-mcp": {
"type": "streamableHttp",
"url": "https://mcp.almirall.com/mcp",
"disabled": false
}
}
}VS Code
{
"servers": {
"almirall-mcp": {
"type": "http",
"url": "https://mcp.almirall.com/mcp"
}
}
}Gemini CLI
gemini mcp add --transport http almirall-mcp https://mcp.almirall.com/mcpClaude Desktop
https://mcp.almirall.com/mcpWindsurf
{
"mcpServers": {
"almirall-mcp": {
"serverUrl": "https://mcp.almirall.com/mcp"
}
}
}Let your agent find its tools
Find servers like Almirall MCP from your agent. Add Koskamo once to search the index for endpoints, access requirements, and client setup. Public discovery needs no key.
Other documentation and reference servers
Do you run Almirall MCP?
Prove ownership with a DNS record, a well-known file, or your Official MCP Registry entry, and your edits publish immediately. Proofs are re-checked weekly; admins can still hide or remove a listing.